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Plant metabolites are compounds synthesized by plants for essential functions, 
such as growth and development (primary metabolites, such as lipid), and specific 
functions, such as pollinator attraction and defense against herbivores (secondary 
metabolites). Many of them are still used directly, or as derivatives, to treat a wide 
range of diseases for humans. There is a demand to explore the biosynthesis of 
different plant metabolites and improve their yield. 
Next-generation sequencing (NGS) techniques have been proved valuable in the 
investigation of different plant metabolisms. However, genome resources for 
primary metabolites, especially lipids, are very scarce. Similarly, using NGS, 
most current studies of secondary metabolites just focus on known 
function/metabolic pathways. Hence, in this dissertation, we systemically 
investigate plant lipid metabolisms and secondary metabolisms by several 
different studies.  
We first develop a reference-based genome assembly pipeline, including mis-
assembled scaffold and repeat scaffold identification components. From the 
evaluation on a gold-standard dataset, we find that these major components in our 
pipeline have relatively high accuracy. 
Next, we use our proposed reference-based genome assembly pipeline to 
construct a draft genome for Dura oil palm. Then, annotations---including protein-
coding genes, small noncoding RNAs and long noncoding RNAs---are done for 
the draft genome. In addition, by resequencing 12 different oil palm strains, 
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around 21 million high-quality single-nucleotide polymorphisms (SNPs) are 
found. Using these population SNP data, lots of sites with a high level of 
sequence diversity among different oil palms are identified. Some of these 
variants are associated with important biological functions, which can guide 
future breeding efforts for oil palm.  
At the same time, a GBrowse-based database with a BLAST tool is developed to 
visualize different genome information of oil palm. It provides location information, 
expression information and structure information for different elements, such as 
protein-coding genes and noncoding RNAs. 
In order to predict new functions/metabolisms for plants, a weighted pathway 
approach is proposed, which tries to consider dependencies between different 
pathways. From the validation results on two different models, we find that the 
weighted pathway approach is much more reasonable than traditional pathway 
analysis methods which do not take into consideration dependencies across 
pathways.   
After applying this weighted pathway approach to an RNA-seq dataset from 
spearmint, several new functions and metabolisms are uncovered, such as energy-
related functions, sesquiterpene and diterpene synthesis. The presence of most of 
these new metabolites is consistent with GC-MS results, and mRNAs encoding 
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Next-generation sequencing platforms are revolutionizing life sciences. Since first 
introduced to the market in 2005, next-generation sequencing technologies have 
had a tremendous impact on genomic research. Next-generation technologies have 
been used for standard sequencing applications, such as genome sequencing and 
resequencing, and for novel applications, such as molecular marker development 
by single-nucleotide polymorphisms (SNPs), metagenomics and epigenomics. 
Plants are the primary source of calories and essential nutrients for billions of 
individuals globally [1]. In addition, plants are also a rich source of medical 
compounds, many of which are still used directly, or as derivatives, to treat a wide 
range of diseases for humans. Plant-derived compounds are called as metabolites, 
which can be categorized either as primary metabolites, necessary for maintenance 
of cellular functions, or as secondary metabolites that are not essential for plant 
growth and development but are involved in plant biotic and abiotic stress response 
and plant pollination.  
Next-generation sequencing has been widely used for understanding plant 
metabolisms. By using next-generation sequencing, draft genomes for unknown 
species and markers for economically-relevant plants for breeding can be generated.  
New noncoding transcripts (long noncoding RNA) and new mRNAs encoding 
enzymes can also be obtained and identified easily. For example, the generation of 
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a draft genome for soybean has been used to study oil production with the aim to 
improve oil yield [2], genome resequencing for soybean and rice has been done to 
explore genetic diversity [3, 4], and transcriptome data from various plants have 
been generated to study the production of secondary metabolites [5-7].  
In this thesis, we present several studies where next-generation sequencing has been 
applied to investigate plant metabolism, with a major focus on lipid and secondary 
metabolite production. The aim of these studies are: 1) to understand biosynthesis 
of different plant metabolites, and 2) to increase metabolite production using data 
generated by next-generation sequencing. 
1.1 Motivation 
1.1.1 Lipids 
Lipids, a major class of primary metabolites, also called fat/oil at room temperature, 
are an essential component of the human diet. Many plant seeds accumulate storage 
products during seed development to provide nutrients and energy for seed 
germination and seedling development. Together, these oilseed crops account for 
75% of the world vegetable oil production. These oils are used in the preparation 
of many kinds of food, both for retail sales and in the restaurant industry. Among 
these oil crops, oil palm is the most productive in the world’s oil market [Table 1.1]. 
However, despite being the highest oil-yield crop, whole-genome sequences and 
molecular resources available for oil palm are very scarce.  
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Table 1.1 Oil production per weight for oil crops [Wikipedia] 
 
Lately large areas of forest are being destroyed to increase the planting areas for 
oil palm. A better strategy would be to increase the palm fruit/seed oil content. To 
increase palm fruit/seed oil content, there are two common methods: molecular 
genetic methods and marker-based breeding.  
Although several lipid-related genes/miRNAs have been successfully cloned and 
investigated in Arabidopsis [8], soybean [9] and Jatropha [10], reports of similar 
genes in oil palm are still very limited. One major reason is the lack of genome and 
transcriptome information. Another reason is that it takes a long time to generate 
transgenic oil palm.  
Apart from molecular genetic methods, during the past thirty years, modern 
breeding methods based on quantitative genetics theory have been extremely 
successful in improving oil productivity in oil palm. Discovery of the single-gene 
inheritance for shell thickness and subsequent adoption of D (Dura) X P (Pisifera) 
planting materials saw a quantum leap in oil-to-bunch ratio from 16% (Dura) to 26% 
(Tenera). Even with the development of next-generation sequencing, it still remains 
a big challenge to identify the most common alleles at various polymorphic sites in 
the oil palm genome and provide data and suggestion for future breeding.   
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1.1.2 Secondary metabolism 
Unlike primary metabolites, secondary metabolites are not involved in essential 
functions of plants. They typically mediate the interactions of plants with other 
organisms, such as plant-pollinators, plant-pathogens and plant-herbivores. 
Secondary metabolites produced by plants have important uses for humans. They 
are widely used in pharmaceuticals, flavors, fragrances, cosmetics and agricultural 
chemical industries [11]. 
Despite the wide commercial application of secondary metabolites, many of them 
are produced in low quantities by the plant. Many of these plants have become 
endangered because of overexploitation.  
In the past, genes involved in plant metabolism were often discovered by 
homology-based cloning [12, 13]. Now, next-generation sequencing technologies 
have provided an opportunity to scientists to simultaneously investigate thousands 
of genes in a single experiment. Therefore, new genes/specific transcripts can be 
discovered and analyzed on a genome-wide basis [14, 15], even without a reference 
genome. Previous works based on transcriptome analysis have mainly focused on 
known enzymes and pathways [16, 17], making these methods applicable to some 
specific plants and known biosynthetic pathways. However, prediction of new 
functions/metabolic pathways for a plant is still a challenge.  
1.1.3 Research challenges 
Next-generation sequencing has a lot of applications in modern plant research.  
 5 
 
With regard to oil palm research, although recently a draft genome for pisifera oil 
palm has been released [18], there are still several challenges for the oil palm 
community: 
 The released genome is constructed by a de novo assembly method with 
229 different insert libraries. However, it still remains a challenge to 
assemble other strains of oil palm with a lower coverage, using this released 
genome.  
 It is very important to investigate the genetic variation and diversity during 
the evolution of oil palm. By identifying polymorphic sites in the genome, 
key breeding markers can be selected for improving oil yield. Hence, it is 
necessary to do resequencing work for other commercial oil palm strains 
to explore their evolutionary history and identify SNP-based markers. 
 Identify specific lipid-related genes for oil palm and use the derived 
sequence information to improve oil yield by molecular genetic approach. 
 Build a comprehensive database of the oil palm genome and transcriptome 
information to be used by biologists. 
For secondary metabolism studies, most of the work mainly focuses on known 
genes/pathways. In the past years, a lot of computational methods on pathway-level 
analysis have been developed, such as over-representation analysis (ORA) [19, 20], 
direct-group analysis [21-23], network-based analysis [24, 25] and model-based 
analysis [26]. Almost all of these methods try to use enzyme expression levels to 
select part or all components of specific pathways for a mutation or a treatment. 




 All pathways are considered independent by these methods, which may be 
not reasonable. They apply the raw expression level of enzymes for each 
pathway, although some enzymes/compounds may be involved in more than 
one pathway. 
 Many major secondary metabolite-related plants do not have a reference 
genome. Consequently, many enzymes in reference pathways are missing. 
This missing information makes applying these methods challenging.  
1.2 Thesis contribution 
Next-generation sequencing is a useful tool for studying plant metabolisms. In our 
study, we focus on lipid and secondary metabolism. For the lipid study, we first 
develop a novel reference-based genome assembly pipeline and apply it to assemble 
the genome of dura oil palm. Then, we investigate the evolutionary history and 
genetic variation of oil palm by reseqeuncing 12 different oil palm strains. Lastly, 
an online database is built to visualize genome information for oil palm. For the 
secondary metabolism study, we introduce a novel weighted pathway approach and 
use it to predict new functions/metabolic pathways for the plants studied.  
Specifically: 
 We generate different genomic libraries for dura oil palm using next-
generation sequencing techniques.  
 We propose a comprehensive reference-based genome assembly pipeline, 




 We resequence 12 different oil palm strains from all over the world. 
 We explore the evolutionary history and genetic variation between different 
oil palm strains.  
 We build a database and a blast tool to show and visualize genome 
information for oil palm. 
 We propose a weighted pathway approach, which takes into account the 
dependency between different pathways. 
 We validate our weighted pathway approach on mint samples (leaf, leaf 
without trichome and trichome tissue), and predict some new 
functions/metabolic pathways for mint.  
1.3 Thesis organization 
The rest of this thesis is organized as follows. Chapter 2 presents some background 
and related work for next-generation sequencing study. Chapter 3 gives details of 
our reference-based genome assembly pipeline. Chapter 4 presents how to apply 
this reference-based genome assembly pipeline to construct a draft genome for 
Dura oil palm. Chapter 5 describes the database and blast tool for oil palm genome 
resource. Chapter 6 discusses the weighted pathway approach. Chapter 7 describes 
how to apply the weighted pathway approach on mint samples. Chapter 8 gives a 
summary of the work and proposes some future research directions.  
1.4 Declaration 
This dissertation is based on the following material: 
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2.1 Next-generation sequencing 
Next-generation sequencing (NGS) techniques became commercially available 
around 2005, the first one being the Solexa sequencing technology [27]. Since then, 
several different methods have been developed, which can largely be grouped into 
three main types: sequencing by synthesis, sequencing by ligation and single-
molecule sequencing. 
Sequencing by synthesis involves taking a single strand of the DNA to be sequenced 
and then synthesizing its complementary strand enzymatically. The pyrosequencing 
method is based on detecting the activity of DNA polymerase (a DNA synthesizing 
enzyme) with a chemiluminescent enzyme [28]. Essentially, the method allows 
sequencing of a single strand of DNA by synthesizing the complementary strand 
along it, one base at a time, and detecting which base is actually added at each step. 
The well-known methods in this group include 454, Illumina and Ion Torrent, 
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Sequencing by ligation is a type of DNA sequencing method that uses the enzyme 
DNA ligase to identify the nucleotide present at a given position in a DNA sequence. 
Unlike sequencing-by-synthesis methods, this method does not use a DNA 
polymerase to create a second strand. Instead, the mismatch sensitivity of a DNA 
ligase enzyme is used to determine the underlying sequence of the target DNA 
molecule [27]. SOLiD and Polonator belong to this group; they differ in their probe 
usage and read length.  
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Single-molecule sequencing (SMS), often termed “third-generation sequencing”, is 
based on the sequencing-by-synthesis approach. The DNA is synthesized in zero-
mode wave-guides (ZMWs), which are small well-like containers with the 
capturing tools located at the bottom of the well. The sequencing is performed with 
the use of unmodified polymerase (attached to the ZMW bottom) and fluorescently 
labeled nucleotides flowing freely in the solution. This approach allows reads of 
20,000 nucleotides or more, with an average read length of 5k bases, such as Pacific 
BioScience's technique [Table 2.1]. SMS technologies are relatively new to the 
market, and in future will become more readily available. 
NGS technologies are evolving at a very rapid pace, with established companies 
constantly seeking to improve performance, accessibility and accuracy, such as 
nanopore sequencing [29], which is based on the readout of electrical signals 
occurring at nucleotides passing by alpha-hemolysin pores covalently bound with 
cyclodextrin. 
The various NGS platforms currently available or under development have 
different methods to sequence DNA, each employing various strategies of template 
preparation, immobilization, synthesis and detection of nucleic type and order [27]. 
These methodological differences produce different sequencing result, such as read 
length, throughput, output and error rates, with each platform having important 
advantages and disadvantages [Table 2.1]. Nevertheless, next-generation 
sequencing technologies are paving the way to a new era of scientific discovery. As 
sequencing techniques become easier, more accessible, and more cost effective, 
genome sequencing will become an integral part of every branch of the life sciences; 
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plant biology is no exception. Hence, in sections below, we summarize the special 
usage of next-generation sequencing in plant biology. 
2.2 Whole-genome sequencing 
It is not surprising that considerable effort has been given to the sequencing of plant 
genomes during the last decades. The dissected genomes enable the identification 
of genes, regulatory elements, and the analysis of genome structure [30]. This 
information facilitates our understanding of the roles of genes in plant development 
and evolution, and accelerates the discovery of novel and functional genes related 
to biosynthesis of plant metabolites. Reference genomes are also important in the 
identification, analysis and exploitation of the genetic diversity of an organism in 
plant population genetics and breeding studies [30].  
The first completed reference genomes in plants, Arabidopsis [31], was a major 
milestone not only for plant research but also for genome sequencing. The approach 
relied on overlapping bacterial artificial chromosomes (BAC) clones that represent 
a minimal tiling path to cover each chromosome arm. The BAC sequences were 
individually assembled and arranged according to the physical map, creating a 
genome sequence of very high quality. The high effort and time associated with this 
approach limited its applicability only to a few plant genomes. Nevertheless, after 
three years, the first crop plant, rice, was also constructed based on the BAC 
approach [32, 33].  
Next, many groups adopted an alternative strategy: whole-genome sequencing 
(WGS). In WGS method, a whole genome is randomly broken down into small 
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pieces, which are then sequenced and subsequently assembled. This method has 
been improved with the use of multiple libraries of different insert sizes. The first 
WGS efforts were mainly implemented on smaller genomes, including Poplar [34], 
Grape [35] and Papaya [36]. These sequencing methods are called first-generation 
sequencing techniques (mainly using Sanger-based methods). Further refinement 
on the WGS approach enables the sequencing of larger genomes, such as Sorghum 
bicolor [37] and soybean [2]. Compared to BAC-based methods, time and cost of 
these projects are reduced a lot. However, the reduction in time and cost is achieved 
at the expense of assembly fidelity in repetitive regions and expanding need for 
computer hardware resources. Although WGS reduced the time and effort 
requirement, genome sequence generation was still expensive and time consuming, 
due to the high cost of Sanger sequencing.  
The use of next-generation sequencing (NGS) platforms in WGS projects improved 
the output and cost ratio of sequencing dramatically. The application of NGS to 
plant genomes has become an increasingly strong trend. Although several plant 
genomes were generated by combination of NGS with Sanger sequencing [38, 39], 
more and more genomes were sequenced using NGS alone. More recently, Illumina 
sequencing emerged as the dominant NGS platform for genome sequencing, 
providing data pools for recent genomes such as Chinese cabbage [40], potato [41], 
orange [42], banana [42] and watermelon [43].  
Despite the advancement of genome sequencing technologies, the downstream 
analysis of short-read datasets after sequencing is a tough task; one of the biggest 
challenges for the analysis of high-throughput sequencing reads is whole-genome 
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assembly. As genome sequencing technologies evolve, methods for assembling 
genomes have to keep step with them.  
At the beginning, although the output was limited, the length of sequencing reads 
was much longer (~460bp for the first published genome). Several assemblers have 
been developed to assemble genomes from these long (“Sanger”) reads, including 
the Celera Assembler [44], ARACHNE [45] and PCAP [46]. These algorithms 
assemble the reads in two or more distinct phases, with separate processing of 
repetitive sequences. First, they assemble reads with unambiguous overlaps, 
creating contigs that end on the boundaries of repeats. Then, in a second phase, they 
assemble the unambiguous contigs together into larger sequences, using mate-pair 
constraints to resolve repeats. They are called Overlap/Layout/Consensus (OLC)-
based assembly methods, which try to connect each read by overlap. More recently, 
the Newbler [47] assembler has been specifically designed to handle 454 Life 
Sciences (Roche) reads, which have a different error profile from that of Sanger 
long reads. 
In principle, assemblers created for long reads can also facilitate assembly of short 
reads. The principles of detecting overlap and building contigs are no different. In 
practice, initial attempts to use previous assemblers for very short reads, which are 
mostly generated by next-generation sequencing platforms, either failed or 
performed very poorly, for a variety of reasons. Some of these failures were easy 
to understand: for example, assemblers impose a minimum read length, or they 
require a minimum amount of overlap, which may be too long for a short-read 
sequencing project. Another problem is that the computation of overlaps is one of 
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the most critical steps in long-read assembly algorithms. Short-read sequencing 
projects may require a redesign of this step to make it computationally feasible, 
especially since many more short reads are generated by next-generation 
sequencing platforms than long-read platforms. For these reasons and others, a new 
group of genome assemblers has been developed specifically to address the 
challenges of assembling very short reads. These assemblers include Velvet [48], 
ALLPATHS [49], ABySS [50], Gossamer [51], oases [52], SparseAssembler [53], 
IDBA [54] and SOAPdenovo [55]. Different from using an overlap graph, all of 
these assemblers are based on de Bruijn graph. In these approaches, the reads are 
decomposed into k-mers that in turn become the nodes of a de Bruijn graph. A 
directed edge between nodes indicates that the k-mers on those nodes occur 
consecutively in one or more reads. These k-mers take the place of the seeds used 
for overlap computation in assemblers for long reads. However, at times, the cost 
of genome sequencing or the biological properties of a genome sequence compels 
a genome to be sequenced at a lower coverage. Since most plant genomes are large, 
cost is still a major factor. Hence, relatively few plant species have been sequenced, 
compared with the hundreds of thousands of species around the world, especially 
for plants with large genome. 
Recently, as more and more reference genomes have been released, there is a 
widespread interest in sequencing large numbers of closely related species or strains, 
by relatively low coverage sequencing. This can help in exploring population 
structure and genetic variation. By aligning the de novo assembly scaffolds to a 
reference genome---thus ordering and orientating the scaffolds---the assembly 
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results can be considerably improved. This process/method is called reference-
based genome assembly; examples include ABACAS [56], PAGIT [57], RACA [58] 
and eRGA [59]. It is a useful technique for genome assembly, due to a lower 
sequencing depth requirement of the target genome.   
Sequencing is a rapidly advancing field, and third-generation sequencing 
technologies have already announced some features with even longer read and 
insert sizes. The use of new sequencing methods and technologies will expand our 
knowledge of plant genomes and contribute to plant genetics. 
2.3 Genome resequencing 
With the development of next-generation sequencing technologies, reference 
genome sequences for many plants are available, cataloguing sequence variations 
and understanding their biological consequences have become a major research aim. 
However, for large eukaryotic genomes such as human or different plants, even 
high-throughput sequencing technologies can only allow deep genome-wide 
sequence coverage of a small number of individuals. However, resequencing the 
genome of many individuals for which there is a reference genome allows 
investigation of the relationship between sequence variation and normal or disease 
phenotypes. When the new sequencing power is targeted to limited areas of large 
genomes [60], it is feasible to study variation in specific regions in thousands of 
individuals. 
By resequencing 50 strains of cultivated and wild rice, molecular genetic analyses 
indicated that indica and japonica originated independently. Meanwhile, 
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population genetics analyses of genome-wide data of cultivated and wild rice have 
also suggested that indica and japonica genomes generally appear to be of 
independent origin [3].  
Another successful application in plants is the resequencing of 31 wild and 
cultivated soybean genomes [4], which has identified a set of 205,614 tag SNPs for 
QTL mapping and marker development.  
For domestic animals, such as chicken [61], by whole-genome resequencing, many 
potential selection loci were found to play important roles during evolution, which 
provided some good evidence for future breeding of domestic animals.   
Increasingly, powerful sequencing technologies are reaching an era of 
individual/personal genome sequences and raising the possibility of using such 
information to guide breeding or medical decisions. Genome resequencing also 
promises to accelerate the identification of disease-associated mutations in plants 
or human. More than 80% of a typical mammalian genome is composed of repeats 
and intergenic or noncoding sequences [5]. Thus, in the future, it is crucial to focus 
resequencing only on high-value genomic regions. Protein-coding exons represent 
one such type of high-value target by many groups, which are commonly called 
exome sequencing [62]. 
2.4 Molecular marker development 
Linkage mapping and evolutionary studies in plants rely on the power of identifying 
and understanding single-nucleotide and insertion-deletion polymorphisms (SNP), 
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which can reflect the differences in a phenotype of interest. This is an important 
approach in improving the yield of crop plants.  
Previous implementation of high-throughput PCR-based marker technologies and 
introduction of first-generation sequencing, such as Sanger sequencing, have 
increased the number of markers as well as the individuals in marker-based studies 
[27]. These new changes enabled a new era in linkage mapping analysis and 
breeding studies in plants, which is called marker-assisted selection (MAS).  
More recently, next-generation sequencing technologies have enabled genome-
wide discovery of SNPs on a massive scale. The 454 platform has some successful 
applications on maize for SNP discovery [63]. However, the higher throughput and 
lower cost of Illumina and SOLiD technologies have made them much more 
popular for major programs when a reference genome is available [64]. Even for 
plant species where high-quality reference genomes are not available [65, 66], some 
reference-free based variant calling methods have been developed to deal with them, 
such as high-quality transcriptome assembly results or some de novo partial 
assemblies from BAC contigs (chapter 2.2).  
Another important family benefitting from NGS is simple sequence repeats (SSRs 
or microsatellites), which are repeating DNA sequences (tandem arrays) of 1-6 
nucleotides that occur in all prokaryotic and eukaryotic genomes. Their high 
mutation rate and polymorphism, multi-allelic and co-dominant nature, and need 
for little DNA for gathering data, make them a good choice for various applications, 
such as linkage map development, quantitative trait loci (QTL) mapping, marker-
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assisted selection, genetic diversity study and evolution study [27, 28]. Previously, 
SSRs were developed by constructing genomic libraries using recombinant DNA 
enriched for a few targeted SSR motifs, followed by isolation and sequencing of 
clones containing SSRs [27]. Based on NGS, sequence of more and more genomes 
for plant species have been determined, which enables the discovery of potential 
SSRs just by de novo searching on the genomes. Zalapa et al. showed the power of 
NGS for developing SSRs in plants through a review of their work in strawberry 
and 95 other studies by next-generation sequencing platforms [67].  
2.5 Transcriptome sequencing 
The sequencing of DNA products (cDNA), which are synthesized from mRNA 
isolates, have played important roles in gene expression analysis, discovery and 
determination of alternative splicing forms of genes (isoforms). For a species with 
a genome available, cDNA sequencing can facilitate the annotation of splicing sites, 
transcribed regions in the genome (such as long noncoding RNA), as well as 
improve gene prediction algorithms [68].  
More recently, the increasing gains from next-generation sequencing techniques, as 
well as improvement in short-gun RNA sequencing (RNA-seq) strategies, have 
provided relatively high coverage for gene discovery, annotation and 
polymorphism discovery in both model and non-model plant species, which are 
rapidly replacing other methods of studying gene expression such as microarrays. 
It is practical in non-model plants, because reference genomes are not required by 
RNA-seq. Similar to algorithms used for genome assembly, several tools, including 
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Trinity [69] and Oases [52], have been developed for RNA-seq assembly, although 
they have slight differences in dealing with alternative splicing. Afterwards, many 
new genes and transcription factors (TFs) have been identified to play roles in plant 
metabolite biosynthesis [6, 70].  
Different from gene-level analysis, some people attempt to shift from analysis of 
individual genes to a set of genes, which perform a specific function together [71]. 
In the past decade, the knowledge which describes---using the standardized 
nomenclature of GO terms---the biological processes, components, and molecular 
functions in which individual genes and proteins are known to be involved in, as 
well as---using the not-so-standardized nomenclature of biological pathways---how 
and where gene products interact with each other, have expanded dramatically. 
Therefore, based on transcriptome expression level by RNA-seq, some researchers 
attempt to analyze them at the functional level. They try to identify interesting GO 
terms or pathways of specific tissue or treatment. These methods include: over-
representation analysis (ORA) [72] which identifies enriched GO terms/pathways 
based on a list of differentially expressed genes, direct-group analysis [73, 74] 
which assigns different scores for different GO terms/pathways, network-based 
analysis [24, 25] which identifies in each pathway a subset of genes most relevant 
to a phenotype, and model-based analysis [26, 75] which uses dynamic models of 
pathways to identify aberrant pathways in a phenotype. Although each of these 
different methods has its own advantages/disadvantages and scope, most of them 
have some successful applications in plant metabolism research. 
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2.6 Non-coding RNA characterization 
RNAs in eukaryotic cells can be classified into five categories: ribosomal RNAs 
(rRNA), transfer RNAs (tRNAs), messenger RNAs (mRNAs), long noncoding 
RNAs (lncRNAs) and small RNAs (sRNAs). Over 90% of the total RNA molecules 
present in a cell are rRNAs and tRNAs, while sRNAs account for ~1% or less. 
Eukaryotic regulatory sRNAs are a subset of sRNAs ranging in size from ~20 to 
30nt; they include microRNAs (miRNAs), small interfering RNAs (siRNAs), and 
piwi-interacting RNAs (piRNAs). The functions of these regulatory sRNAs are 
conserved from plants to animals, which imply their involvement in fundamental 
cellular processes. Discovery and profiling of these regulatory sRNAs are of 
primary interest in unraveling their regulatory functions.  
In the past, various experimental methods---including cloning, Northern blot, 
RNase protection assay and primer extension---have been applied to quantify and 
identify novel small RNAs. After the discovery of the fold-back structure 
characteristic of lin-4 and let-7 [76], many small RNAs were identified by cloning 
and sequencing. Although cloning and sequencing is a very useful method for the 
identification of individual novel miRNAs, there are still limitations for this method. 
First, it requires a lot of total RNA, which is not practical in many cases. In addition, 
due to low coverage, some small RNAs with low abundance may be missed. 
Sometime, it is very difficult to distinguish between miRNAs and other ncRNAs, 
rRNAs or tRNAs. To avoid these limitations, many researchers have adopted 
Northern blotting analysis [77], which can efficiently detect miRNAs. RNase 
protection assays are mainly used to detect mature miRNAs [78]. 
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Microarray technology is a further step toward high-throughput quantification of 
miRNA expression, and it has also been used to explore miRNA expression in 
various tissues and development stages [79]. A good case is miRNA microchip, 
which is specifically designed for miRNA profiling on a global level [80]. 
Compared with other experimental methods, miRNA-specific arrays have several 
advantages. First, the expression of multiple RNAs can be detected and measured 
at the same time. Second, the expression of mature and precursor miRNAs can be 
detected simultaneously by some careful probe design strategy. In addition, less 
amount of RNA is needed, when compared to that required for other experimental 
methods, such as Northern blot.  
Although cloning and sequencing of small RNAs can discover novel miRNAs, it is 
time consuming and limited to the most abundant small RNAs. Real-time PCR 
enables rapid detection of miRNAs and their precursors, but has limitations on 
novel miRNA identification. miRNA-related arrays also have limitations on novel 
miRNA identification. In contrast, high-throughput sequencing not only 
revolutionizes mRNA discovery, but also accelerates the discovery of small RNAs 
and reveals their expression patterns. For species with a known reference genome, 
just by mapping and structure checking, many known and novel small RNAs can 
be easily detected. For example, using the Solexa platform, the NK cell miRNA 
transcriptome has been investigated to study miRNA roles in NK cell biology, and 
21 novel miRNA genes have been discovered [81]. Using the Illumina platform, 
novel miRNAs, phased smRNA clusters and small-interfering RNAs have been 
identified in Arabidopsis [82].  
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Therefore, with the development of small RNA sequencing, many associated 
bioinformatics software and tools---e.g., miRDeep [83], UEA small RNA tools 
[84]---have been developed to identify known and novel miRNAs with sequencing 
reads and reference genomes. Particularly, for plants whose genome information is 
unavailable, small RNA sequencing shows remarkable superiority over other 
methods.  This is because the small RNA reads can be mapped to public small 
RNA database to identify the known small RNAs. However, it is still a challenge 
to identify novel miRNAs for these species.  
Apart from small-RNA profiling, identification of long noncoding RNAs also 
benefits greatly from next-generation sequencing. Some researchers attempt to 
detect long noncoding RNAs by identifying trimethylation of lysine 4 of histone 
H3 (H3K4me3) peaks at their gene promoter and trimethylation of lysine 36 of 
histone H3 (H3K36me3) peaks along the length of the transcribed gene region 
based on CHIP-seq technique [85]. However, most researchers employ RNA-seq 
to detect long noncoding RNAs using the hypothesis that all un-annotated 
transcripts in the genome, which can be transcribed, but not translated, could be 
considered as potential long noncoding RNAs. Using RNA-seq, the transcribed 
regions in the genome can be found easily, which are good candidates for long 
noncoding RNAs. 
As NGS technologies continue to improve, their scope and application will 
correspondingly expand within and across scientific research. Plant biology has 
gained much from increasing capacity in genomics, plant breeding, evolutionary 
studies and biosynthesis of different products/metabolites. In this thesis, we 
 24 
 
introduce several studies to understand plant metabolism using next-generation 



















REFERENCE-BASED GENOME ASSEMBLY 
In Chapter 2, we have mentioned that considerable effort has been devoted to the 
sequencing of plant genomes during the last two decades. This is because a 
sequenced genome enables the identification of genes, regulatory elements, and the 
analysis of genome structure [30]. Moreover, this information facilitates our 
understanding of the roles of genes in plant development and evolution, and 
accelerates the discovery of novel and functional genes related to biosynthesis of 
plant metabolites. 
The development and commercialization of next-generation massively parallel 
DNA sequencing technologies—including Illumina’s Genome Analyzer (GA) 
[86], Applied Biosystems’ SOLiD System, and Helicos BioSciences’ HeliScope 
[87]—have revolutionized genomic research. The use of next-generation 
sequencing (NGS) platforms in whole-genome sequencing projects has improved 
the output and cost ratio of sequencing dramatically. The application of NGS to 
plant genomes has become an increasingly strong trend.  
In the past two decades, as genome sequencing technologies evolve, methods for 




According to the scope and theory, NGS assemblers are commonly classified into 
two major categories: Overlap/Layout/Consensus (OLC)-based assembly methods 
and de Bruijn Graph (DBG)-based assembly methods.  
3.1.1 OLC-based assembly methods 
In the traditional approach, assembly is formalized using the overlap graph. This 
structure represents each sequencing read as a separate node, where two reads 
presenting a clean overlap are connected by a directed edge. These algorithms 
assemble the reads in two or more distinct phases, with separate processing of 
repetitive sequences. First, they assemble reads with unambiguous overlaps, 
creating contigs that end on the boundaries of repeats. In the second phase, they 
assemble the unambiguous contigs into longer sequences, using mate-pair 
constraints to resolve repeats. Newbler (454/Roche), ARACHNE [45], Edena [88] 
and SGA [89] belong to this category of methods. They are called 
Overlap/Layout/Consensus (OLC)-based assembly methods, which try to connect 
each read by overlap. 
However, this approach has two serious shortcomings that make it applicable for 
long-read sequencing only, like those produced by 454 sequencing technique. 
Firstly, the link of the two reads is determined by the overlap nucleotide sequence, 
and this overlap has to be sufficiently long to ensure a reliable link. For example, 
in a study by Narzisi and Mishra [90], they found that compared to other de novo 
assembly methods, an OLC-based method---Edena---not only produced smaller 
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N50 size, but also a larger number of total scaffolds on a short-read dataset for a 
known genome [Table 3.1]. Hence, this method is only applicable to long reads, not 
applicable to short sequences, such as those produced by Illumina sequencing. 
Table 3.1 Comparison between different assemblers on short reads example for a known genome [90] 
 
Secondly, the computation of pairwise overlaps is inherently quadratic in 
complexity, although it can be optimized by heuristics [91] and filters [92]. For 
short-read sequencing, several hundred million reads are typically produced. Thus 
this quadratic time complexity is not acceptable.   
In summary, due to the large-size requirement for the reads and computation time 
limitation, methods based on this approach are only applicable for low-throughput 
long-read sequencing datasets. 
3.1.2 DBG-based assembly methods 
In 1995, Idury and Waterman [93] introduced the use of a sequence graph to 
represent an assembly. They presented an assembly algorithm for an alternative 
sequencing technique, sequencing by hybridization, where an oligoarray could 
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detect all the k-nucleotide words, also known as k-mers, present in a given genome. 
By connecting the nodes (k-mers) corresponding to every detected word, they could 
produce contigs, which are chains of overlapping k-mers. 
Pevzner et al. [94] expanded on this idea. Firstly, they proposed a slightly different 
formalization of the sequence graph, called a de Bruijn graph, whereby the k-mers 
are represented as arcs and overlapping k-mers join at their tips. For the k-mers, 
users can adjust by themselves, which removes the size limitation of overlap-based 
methods. A lot of software based on de Bruijn graph have now been developed, 
such as SOAPdenovo [55], SparseAssembler [53], ABySS [50], Velvet [48], oases 
[52], IDBA [54], Minia [95] and Allpaths LG [49], which use different techniques 
to deal with repeats and tips. Most of them have been successfully applied to 
construct the draft genome of different species [42, 43, 96, 97], with more than 
100x coverage. These drafts are of high quality, and, although imperfect, have 
served as references for the community. 
However, at times, the cost of genome sequencing or the biological properties of a 
genome sequence forces a genome to be sequenced at a lower coverage. Since 
mammalian genomes are large, cost is a major factor. Hence, it is still a challenge 
for genome assembly with lower sequence coverage.  
3.1.3 Reference-based genome assembly 
The recent development of ultra-high-throughput sequencing technologies and the 
sequence assembly approaches mentioned in previous sections have led to a huge 
increase in the number of genome sequencing projects being carried out [98]. In 
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particular, there is widespread interest in sequencing a large number of closely 
related species or strains, where a high-quality reference genome already exists, by 
low-coverage sequencing. This can help in exploring population structure and 
genetic variation.  
By aligning the de novo assembly scaffold to a reference genome---thus ordering 
and orientating the scaffold---the assembly results can be improved a lot. This 
process/method is called reference-based genome assembly. It is a useful technique 
to genome assembly by lowering the sequencing depth requirement of the target 
genome.   
In the past several years, four such assemblers---viz, ABACAS[56], PAGIT[57], 
RACA [58] and eRGA [59]--- have been developed for carrying out both de novo 
assembly and mapping assembled scaffolds to reference genome.  
eRGA focuses on merging results from de novo assembly and raw-read alignment 
methods; strictly speaking, it is not a reference-based assembly tool.  
ABACAS first conducts a de novo assembly and then aligns the resulting 
contigs/scaffolds to a reference genome to obtain much longer ones. However, it 
suffers from several disadvantages: 
 it filters scaffolds by the Identity criteria [Identity criteria: percentage of 
match  region between scaffold and target reference genome], which may 
discard some mis-assembled scaffolds;  
 it randomly assigns repeat scaffolds to the reference genome;  
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 it is only applicable to a reference genome that has one chromosome.  
PAGIT is a unified software based on a series of previous software and, in particular, 
ABACAS is its main component. RACA tries to construct synteny block between 
different scaffolds. However, they also don’t deal with mis-assembled scaffolds and 
overlap scaffolds. 
The reference-based genome assembly approach has been successfully used to 
assemble four different Arabidopsis genomes [99]. However, the pipeline used in 
that study is based on alignment of raw reads to a reference genome, which may 
miss some rearrangement parts, despite having some extension mechanism to 
mitigate this problem.  
3.2 Methods 
In section 3.1.3, we have mentioned that there are several disadvantages in existing 
reference-based genome assembly methods. To overcome these disadvantages, we 
propose some new components to form a new pipeline for reference-based genome 
assembly: 
 In order to solve the problem caused by mis-assembled scaffolds, we first 
try to identify the mis-assembled scaffolds. Then, we correct these mis-
assembled scaffolds. 
 For the repeat scaffolds, we do not randomly assign them a location in the 
reference genome. According to a hypothesis to be stated later, some of 
them are assigned to multiple locations.  
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 If all chromosomes of a reference genome are merged into one combined 
sequence, it will cost a lot of memory when doing alignment between 
scaffolds and the reference genome. Hence, in our proposed pipeline, they 
will be considered separately.  
In summary, we are proposing a much more comprehensive pipeline for reference-
based genome assembly [Figure 3.1]. In particular, our proposed pipeline has five 
components: 1) de novo assembly, 2) mis-assembled scaffold identification and 
correction, 3) alignment to a reference genome, 4) repeat scaffold identification, 
and 5) resolution of overlapping scaffolds. We discuss each component of our 
pipeline in the following sections. 
Figure 3.1 Pipeline of our proposed reference-based genome assembly pipeline 
 
3.2.1 De novo assembly 
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As introduced in earlier sections, many different de novo assembly tools have been 
developed for different sequencing results. From a comparison of running time and 
RAM for different assembly methods [Table 3.2], the DBG-based methods 
SOAPdenovo [55] and ABySS [50] consume less RAM and time, especially for a 
large genome [part of human genome with size of 100.5M bp]. Considering this 
superior performance and the features of our sequencing data sets, these DBG-
based methods should be adopted for our analysis.  
Hence, both of them and other well-known tools---IDBA [54], Velvet [48], Oases 
[52], SparseAssembler [53], Gossamer [51] and Allpaths-LG [49], which also have 
less RAM and time costs---are used to do the first de novo assembly step.  
Table 3.2 Comparison of running time (Runtime) and RAM for different de novo assembly method [100]. SE 
denotes single-end sequencing dataset. PE denotes pair-end sequencing dataset. E.coli, C.ele, H.sap-2, 
H.sap-3 denotes four different test dataset. Second column denotes different de novo assembly method. -





Among these approaches, the one producing the longest N50 and larger genome 
coverage [>85%] is then selected for use in the downstream analysis in our pipeline.  
3.2.2 Mis-assembled scaffold identification and correction 
Although there are many successful de novo assembly tools [48-50, 54, 55], there 
are many mis-assembled scaffolds in their output, especially for large genomes, 
due to sequencing errors and repeat regions. If these mis-assembled scaffolds are 
not corrected, most of them will be excluded by the Identity (percentage of length 
of match region and total length of scaffold) criterion in typical reference-based 
assembly methods and, thus, negatively impacting the completeness of the 
resulting assembled genome. Hence, it is necessary to identify and correct mis-
assemblies before aligning them to the reference genome in reference-based 
genome assembly methods.  
Figure 3.2 An example of a mis-assembled scaffold [scaffold148].  a. the coverage across the scaffold 148 
by insert size of pair end reads  b. the detail alignment information for scaffold 148 after aligning to the 
reference genome. In this figure, t denotes target reference genome, q denotes query assembly scaffolds.  
 
Consider the example scaffold 148 in Figure 3.2.b. It shows the alignment result 
between the scaffolds and the reference genome. From the alignment result, we 
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can see that two different parts from this scaffold are located in two different 
chromosomes of the reference genome. One has 20.77% Identity, and the other 
one has 44.62% Identity. Both of them will be filtered in the final scaffold sets by 
the Identity criteria, as the default setting for ABACAS is 70%.  
However, if it is a mis-assembled scaffold, it should be first split into two parts at 
the mis-assembly region. Then, for each part, the Identity parameter is computed 
based on the length of that part, not the total length of the scaffold. This way, both 
parts will be kept and put in different chromosomes in the final assembled 
genome.  
In order to avoid subsequent assembly error when aligning to the reference 
genome, mis-assembled scaffolds are identified first in our work.  
Figure 3.3 Model of assembly by pair end reads. The arrow denotes pair end reads 
 
In a correctly assembled scaffold [like the example in Figure 3.3], there should be 
pair end reads spanning the whole region of this scaffold. In other words, each 
position in this scaffold should be covered by the insert size of some pair end 
reads. If some region is not covered this way, it may be mis-assembled.  
Based on this hypothesis, our method uses the insert size of pair end reads to 
identify mis-assembled scaffolds.  
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The process is detailed below: 
 The region for each scaffold is divided into equal and contiguous bins 
(window) [bin=10bp] [Figure 3.3]; 
 After aligning the raw reads into the assembled scaffolds, the coverage of 
each bin is computed by the insert size of pair end reads. As a control, pair 
end reads that are put in bins that are too far apart or too close together---
beyond the 95% confidence interval of the real insert size---are discarded.  
 The zero-coverage regions are identified as potential mis-assembly 
regions. 
Considering the same example shown in Figure 3.2.a, it shows the distribution of 
coverage of each bin across scaffold 148. From the result, we see that there is a 
region which has zero coverage. According to our hypothesis, this scaffold should 
be a mis-assembled scaffold. 
After identifying mis-assembled scaffolds, we split them into several new 
scaffolds at the mis-assembly regions. Consider the example---scaffold 148---in 
Figure 3.2. There is just one mis-assembly region [between 845*10 and 2041*10]. 
Hence, we split it into two parts: 1-8450 and 20410-end.  
3.2.3 Alignment to reference genome 
After mis-assembly scaffold identification and correction, the new scaffold sets are 
aligned to the reference genome using MUMmer [101], due to its efficiency. 
MUMmer has commonly been used in the discovery of syntenic regions and 
chromosome-scale inversions [102]. For our purpose, we mainly use it for 
alignment between our corrected de novo assembly result and the reference genome. 
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The alignment result helps us determine the order and orientation of scaffolds. 
However, as a quality control, any scaffold which has a low Identity[<80%] on the 
reference genome will be filtered.  
3.2.4 Repeat scaffold identification 
As we mentioned earlier, one major drawback of ABACAS [56] is that it just 
randomly assigns each repeat scaffold to a matching location in the reference 
genome. However, a real repeat scaffold should have multiple alignment locations 
in the reference genome, and we should retain all of them. For a non-repeat scaffold, 
if it has multiple alignment locations in the reference genome, this may be because 
of some rearrangement between the reference genome and the target genome; in 
this case we should retain the target location with the highest Identity and matching 
quality, not all locations.  
Therefore, before dealing with the repeat scaffolds in the alignment result, we 
should first check which one is a real repeat scaffold. Repeat scaffold always refers 
to DNA sequences that are present in multiple copies in the genome in which they 
reside. Hence, for genomic sequencing, the reads abundance for sequences 
corresponding to these regions is always higher than other regions.  
Based on this fact, our method for identifying repeat scaffolds is similar to mis-
assembled scaffold identification. The only difference is that the windows/bins 
coverage is computed by pair end reads coverage [Figure 3.3], not by insert size. 
The pair end reads coverage means the read coverage for specific regions, which 
mainly measures the abundance for this scaffold.  
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It also contains three steps: 
 The region for each scaffold is divided into equal and contiguous bin 
(window) size [10bp] [Figure 3.3].  
 The coverage of each window is computed by the coverage region of each 
reads.  
 Average coverage for each scaffold is given by: 
    
                𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 =




Note: for a scaffold with gaps, the bin of each gap is excluded in the   
calculation—because no reads are mapped to the gap. 
If the average coverage of a scaffold is much bigger than the expected value [the 
default value in our pipeline is mean+2*stdev], it may be a repeat scaffold [Figure 
3.4]. 
Figure 3.4 An example coverage comparison between a repeat scaffold and a non-repeat scaffold 
  
3.2.5 Overlap scaffold identification 
Another case that needs attention is that, there are some overlapping scaffolds after 
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alignment to the reference genome. This may be due to some partial repeat region 
or tips of repeat sequence during de novo assembly, like the example shown in 
Figure 3.5. Before ordering and orientating the scaffolds, we also need to develop 
a method to deal with this type of scaffolds.  
Our method for dealing with this case can be summarized into two steps; see Figure 
3.5: 
Step 1: The raw reads aligned to these regions are extracted to form a new read set. 
Step 2: Using this new raw read set, we redo the de novo assembly for this region 
and obtain a unified scaffold. 
Figure 3.5 A method to deal with the overlap scaffolds 
 
In summary, combining these five components, we can order and orientate all the 
scaffolds located in the same chromosome of a reference genome into a much 





3.3.1 Evaluation on gold-standard dataset 
Before applying the proposed reference-based genome assembly method to our 
real plant sample, we first test each component of our method on a gold-standard 
data set [103] from a simulated genome [112,498,656bp] produced by the Evolver 
suite of genome evolution tools (http://www.drive5.com/evolver). Evolver can 
simulate the forward evolution of multi-chromosome haploid genomes, and it 
includes models for evolutionary constraint, protein codons, genes and mobile 
elements. We use it to generate several pair end datasets with different insert 
libraries, according to the error model that Illumina protocols introduce. 
In the final generated sequencing libraries, the total coverage for the whole 
genome is around 120X [Table 3.3]. In order to test the effectiveness of our 
method on low-coverage sequencing results, we randomly selected several subsets 
of this (repeat 3 times at each coverage level in our study) dataset and finally get 
test sets with 100x, 80x, 60x, 40x, 20x and 10x coverage (3 replicates). 
Table 3.3 Statistic of sequencing information for gold dataset 
library read num seq 
length 
total base coverage pair end 
200bp 22,499,730 100 4,499,946,000 40X yes 
300bp 22,499,730 100 4,499,946,000 40X yes 
3000bp 11,249,867 100 2,249,973,400 20X yes 
10000bp 11,249,867 100 2,249,973,400 20X yes 
3.3.2 Evaluation of mis-assembly detection component 
An important component in our pipeline is mis-assembly scaffold identification. 
Therefore, we evaluate its accuracy on the gold-standard data, which has been 
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introduced in section 3.3.1. 
First, we apply several known de novo assembly tools on the test sets at different 
coverage (120x, 100x, 80x, 60x, 40x, 20x, 10x) of the gold-standard dataset. 
Then, we use our mis-assembly component to evaluate them. The number of mis-
assembled scaffolds reported for various de novo assembly methods is shown in 
Table 3.4.  
At the same time, for this gold-standard dataset, it has a known genome. Hence, 
by aligning the assembled scaffolds to the reference genome, we know which 
scaffold is a real mis-assembled scaffold and where the mis-assembly regions are. 
Considering the same example shown in Figure 3.2.b, after aligning scaffold148 
to the reference genome, one part [1-8,447] and another part [20,436-40,433] are 
located in two different chromosomes. By our identification method shown in 
Figure 3.2.a, the mis-assembly region is also located in region spanned by the 
845th to 2041th bins. After multiplying by bin size, this is [8,450-20,410]. Hence, 
the result produced by our method is consistent with the real mis-assembled 
region. 
Table 3.4 shows the average number of scaffolds reported by our method to be 
mis-assembled when it is applied to the test sets at various levels of coverage. 
From the results, we find that there are fewer mis-assembled scaffolds at higher 
sequencing coverage. It may be because the accuracy for these de novo assembly 
methods are higher at higher sequencing depth, such as having more reads for 
resolving repeat bubbles in the de Bruijn graph. However, at 20x coverage, there 
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is a huge increase of possible mis-assembled scaffolds. An explanation can be 
inferred from the total number of assembled scaffolds shown in Figure 3.6. 
Generally, the total number of assembled scaffolds is decreasing with decrease of 
sequencing coverage, because more and more regions (especially those of lower 
abundance) of the genome may not be included in the lower-coverage test sets. 
However, there is a big increase of assembled scaffolds at 20x coverage; this is 
because some previously covered regions (even those of higher abundance) get 
broken into short fragments in the final assembly at 20x coverage. At this low 20x 
coverage, it is much more difficult to deal with repeat bubbles, which in turn 
results in much more mis-assembled scaffolds. At 10x coverage, many of these 
fragmented higher abundance regions may be also not be included in the 10x 
coverage test set, leading to very few scaffolds.     
Table 3.4 Mis-assembly result based on the gold-standard data from Assemblathon 1 [103]. The number 
means the average number of mis-assembled scaffolds reported by our method. 
 120x 100x 80x 60x 40x 20x 10x 
abyss 2 1 1 1 3 4,786 1 
Gossamer 13 17 23 15 10 2,496 3 
SOAPdenovo 35 56 20 12 4 2,177 0 
SparseAssembler 1,436 1,458 1,408 1,398 1,219 21,687 184 
IDBA 1 1 14 2 3 1,363 207 
velvet 7 1 1 75 2 10,556 93 
oases 12 3,879 4,327 5,090 5,631 4,069 5,479 
 




As shown in Figure 3.7, at 80x coverage, about 80% of the reported mis-
assembled scaffolds have been verified correct. At 60x coverage, 75% of them are 
correct. Even at 40x coverage, around 65% of them are correct. Only at very low 
coverage (20x and 10x), the percentage is a little low. 
However, for our purpose, even around 65% accuracy is acceptable. This is 
because, if a scaffold was wrongly identified by our method to be mis-assembled, 
the segments (resulting from the split in our method) actually would align side by 
side in the reference genome. Consequently, these scaffolds would also be kept 
and not so much information is loss. On the other hand, the correctly identified 
mis-assembled scaffolds, if they were not identified and corrected, would likely 
be discarded as they would not match the reference genome at a sufficient level 
by Identity criteria, resulting in a loss of information. 
Figure 3.7  Percentage of correct mis-assembled scaffolds reported by our method for each de novo 
assembly method under different coverage of the raw genome 
 
In summary, based on the evaluation on different coverage of this gold-standard 
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dataset, our method for mis-assembled scaffold identification has relatively high 
effectiveness. 
3.3.3 Evaluation of repeat-scaffold detection component 
Similarly, before applying the repeat scaffold identification method to our real plant 
samples, we also test it on these same gold-standard data sets [103] used earlier in 
mis-assembled scaffold identification.  
After aligning the assembled scaffolds to the known reference genome, the number 
of scaffolds having multiple locations in the reference genome is shown in Table 
3.5.  
Table 3.5 Repeat scaffold result based on the gold-standard data from Assemblathon 1 [103]. The number 
is the average number of scaffolds mapped to multiple locations in the reference genome for different 
methods. 
 120x 100x 80x 60x 40x 20x 10x 
abyss 442 539 353 535 126 293 30 
Gossamer 2,563 2,098 6,614 1,082 91 315 22 
SOAPdenovo 7,634 6,759 1,671 1,785 56 132 21 
SparseAssemble
r 
9,710 8,151 3,937 5,928 276 300 58 
IDBA 31,586 21,455 3,505 3,846 207 234 144 
velvet 61,586 41,763 29,658 9,782 4,793 686 638 
oases 28,785 24,042 7,320 8,761 317 312 95 
 
Using our repeat-scaffold identification component, more than 80% of these multi-
location scaffolds can be detected, for the 120x, 100x, and 80x test sets [Figure 3.8]. 
Even the lower-coverage test sets, such as 60x and 40x, our method achieves around 
75% recall [Figure 3.8]. 
 44 
 
Figure 3.8 Recall for our repeat scaffold identification component 
 
However, as shown in Figure 3.9, the precision of our repeat-scaffold identification 
method is only around 50%. There may be several reasons for this problem: 
First, some of these may be real repeat scaffolds; however, they are missed in the 
reference genome due to sequencing error or other reasons. These false positives 
are potentially true positives; their status may be confirmed by checking against 
known repeat motifs.  
Second, some of these may be in regions that are over amplified. It may be possible 
to eliminate this category of false positives by checking whether their flanking 
regions also have high abundance. 
Third, there may be a divergence between the reference genome and the genome 
being assembled.   
Although the precision is only about 50%, this is also not critical for our purpose. 
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A scaffold is a false-positive repeat scaffold means that it does not align to multiple 
locations in the reference genome. Thus it is mapped to at most one location in the 
reference genome, and no information is lost. In contrast, if the recall is low, it 
would cause a loss of information, as a missed repeat scaffold that should be 
mapped to multiple locations in the reference genome is mapped to only one 
location. 
Figure 3.9 Precision for our repeat scaffold identification component 
 
Hence, based on our method, if a scaffold has multiple alignment locations in the 
reference genome and is identified as a repeat scaffold by our method, we retain all 
the locations and multiple copies in the final scaffold sets. However, for a scaffold 
that is not a repeat scaffold under our criteria, we just retain the copy with the 
highest match score, even when it has multiple alignment locations in the reference 




3.3.4 Evaluation of overlap-scaffold detection component 
Similar to the previous two sections, we also investigate the statistics of overlap 
scaffolds in the gold-standard data [103]. From Table 3.6, it is clear that overlap 
scaffold groups form a relatively high portion even for this small simulated genome. 
It is obviously necessary to redo the assembly for overlapping scaffold groups in 
real datasets. 
Table 3.6 Average number of overlap scaffold groups based on the gold-standard data from Assemblathon 
1 [103] at different coverage. 
 120x 100x 80x 60x 40x 20x 10x 
abyss 1,426 1,380 1,238 958 884 7,433 98 
Gossamer 1,468 1,405 1,429 342 155 16,202 23 
SOAPdenovo 16,663 17,058 8,143 2,267 402 5,064 8 
SparseAssembler 7,178 6,259 4,484 2,829 1,976 5,089 292 
IDBA 40,635 33,672 18,192 17,207 3,066 4,458 552 
velvet 66,688 56,630 79,159 87,799 73,521 55,701 16,391 
oases 41,878 38,159 26,990 12,282 8,833 9,873 1,028 
 
In summary, by these evaluations, we find that these important components in our 
pipeline are necessary and have relatively high accuracy. In the next Chapter, we 
will discuss how to apply our reference-based genome assembly pipeline in a real 
plant genome project, and make comparison with de novo assembly tools and other 
reference-based genome assembly tools. 
3.3.5 Comparison between de-novo and reference-based genome assembly 
In order to better appreciate the performance of de-novo assembly methods and 
reference-based assembly methods, we also compare the final results on the same 




Figure 3.10 N50 for different method under different coverage of genome.  
 
From the result shown in Figure 3.11, we can see that if we want to get more than 
90% coverage of the whole test genome using de novo assembly, the raw 
sequencing coverage has to be at least 100x, even 120x. With 80x and 60x raw 
sequencing genome coverage, we can just have around 85% coverage for genome. 
However, by reference-based genome assembly, even at 60x sequencing coverage, 
we can get around 90% of genome coverage. From the N50 distribution in Figure 
3.10, reference-based genome assembly methods also outperform de novo 









Figure 3.11 Final genome coverage by de novo assembly methods. Genome coverage=total number of bases 
of final scaffolds/genome size 
 
Hence, from these comparisons on final assembly results, we see that reference-
based genome assembly [ABACAS and our method] methods outperform de-novo 
assembly methods, not only on N50, but also on whole-genome coverage [Figure 
3.10 and 3.11]. In addition, our method slightly outperforms other reference-based 
methods, such as ABACAS, on this gold dataset. 
3.4 Conclusions 
In this chapter, we have proposed a new reference-based genome assembly pipeline. 
The main novel features for our pipeline are the techniques for detecting and 
handling mis-assembled scaffolds, repeat scaffolds and overlap-scaffolds.  
From the evaluation on a gold-standard dataset, we find that these major novel 





APPLICATION ON OIL PALM 
Lipids, a major class of primary metabolites, also called fat/oil at room temperature, 
are an essential part of the human diet. Many plant seeds accumulate storage 
products during seed development to provide nutrients and energy for seed 
germination and seedling development. Some seed crops---such as corn, wheat, rice, 
peas and common beans---accumulate starch as the main form of energy storage in 
the seeds. However, oilseeds---such as soybean, corn, coconut, jatropha and oil 
palm---accumulate oil instead of starch. Together, these oilseed crops account for 
75% of the world vegetable oil production. These oils are used in the preparation 
of many kinds of food, both for retail sales and in the restaurant industry. Among 
these main oil crops, oil palm is the highest oil-producing crop in the world’s oil 
market since 2005 [Figure 4.1].  





To increase the production of oil crops, a simple method is to increase the planting 
area. However, it is not sustainable to keep extending planting area, because of 
increased competition for land by the rapidly rising population. Therefore, it is a 
better strategy to increase fruit/seed oil content than to increase the planting area.  
In recent years, molecular genetics approaches, based on homolog search or 
screening, have been successfully used to modify seed oil content for several plants. 
For example, over-expression of a diacylglycerol acyltransferase (AtDGAT) cDNA 
in wild-type Arabidopsis thaliana enhanced oil deposition and average seed weight 
[8]. The research of Wang et al. suggests that oil content of soybean seeds can be 
increased by up-regulation of two soybean Dof-type transcription factor (GmDof) 
genes, that are associated with fatty acid biosynthesis [9]. Several researchers have 
found that the mutation of FAD2 and FAD3 can regulate oil composition and 
elevate oleic acid levels [104-107]. Although the biochemical pathways that 
produce different oil components are well characterized, there is still no genome-
wide model to identify new genes/enzymes involved in lipid biosynthesis.   
With the development of high-throughput technologies, including the newly 
developed Solexa/Illumina RNA-sequencing, new genes/specific transcripts can be 
easily discovered and analyzed on a genome-wide model. In the research of Severin 
et al. [15], RNA-seq provided a record of high-resolution gene expression in a set 
of various tissues for soybean. By differential analysis, they also found dramatic 
highly-expressed genes and the genes specific to legumes in seed development and 
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nodule tissues. Different from their RNA-level analysis, based on genomic 
sequencing techniques, the whole genome for many oil crops such as soybean [2], 
corn [108], sesame[109], coconuts [110] and jatropha [10] have been dissected 
[111]; see Figure 4.2. Thus, many new and specific lipid biosynthesis 
genes/enzymes, and even new biosynthesis pathways, have been discovered using 
these draft genomes [105, 107, 112].  
However, as the highest oil-yielding crop, whole-genome sequence and molecular 
resources available for oil palm still remain scarce [113]. Only several months ago, 
while this work was in progress, a draft genome of Pisifera was released [18, 114], 
which is different from the commercial Dura strain we work on. To provide oil palm 
researchers with additional resources to study and improve this important oil crop, 
we attempt to construct a draft genome and transcriptome resources for Dura based 
on next-generation sequencing data sets. 
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Figure 4.2 Plant genomes which have been finished [111] 
 
4.2 Methods 
4.2.1 Whole-genome short-gun (WGS) sequencing for oil palm 
The increasing use of next-generation sequencing (NGS) has resulted in an 
increased growth of the number of de novo assembled genomes [Figure 4.2]. In our 
study, short-insert pair-end (clone size: 300 bp) and large-insert mate-pair (3-5,10 
and 20 kb) libraries were prepared and sequenced by Illumina and 454 technologies 
following the manufacturers’ instructions, and the resulting sequences were used to 
assemble the Dura draft genome [Table 4.1]. Summarizing these sequence data, we 
obtained 92X sequence coverage for the entire genome. 
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raw reads usable reads usable base (bp) Pair 
end 
depth Technology 
300 101 558,695,836 406,267,011 39,396,057,965 Yes 43.8 Illumina 
300 101 374,109,317 325,921,739 32,366,281,947 Yes 36 Illumina 
3-5k 51 144,845,306 144,845,306 7,387,110,606 Yes 8.2 Illumina 
3-5k 51 37,083,563 37,083,563 1,854,178,150 Yes 2.1 Illumina 
10k 51 26,355,787 26,355,787 1,344,145,137 Yes 1.5 Illumina 
20k 404.08 558,411 558,411 225,642,316 yes 0.13 454 
NA 378.28 1,322,072 1,322,072 500,110,270 no 0.28 454 
Total        
  1,142,970,292 942,353,889 83,073,526,391  92  
4.2.2 Reference-based genome assembly 
Considering the large genome size of our Dura sample and the released genome of 
another strain of oil palm, our proposed reference-based genome assembly is 
adopted to construct the draft genome for Dura oil palm [Figure 3.1]. 
In the de novo assembly part, SOAPdenovo [55], ABySS [50], IDBA [54], Velvet 
[48], Oases [52], Gossamer [51], SparseAssembler [53] and Allpaths-LG [49] are 
selected for comparison.  
4.3 Results 
4.3.1 Evaluation method  
Several metrics are commonly used for assessing the assembly results. 
 Number of the assembled scaffolds 
 Total length of the assembled scaffolds 
 Length of the largest scaffold 
 N50 of contigs/scaffolds: N50 is similar to a mean or median, but greater 
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weight is given to the longer scaffolds. Given a set of scaffolds, each with 
its own length, the N50 length is defined as the length for which the 
collection of all scaffolds of that length or longer contains at least half of 
the total of the lengths of the scaffolds. Sometimes, some researchers also 
show the N90, N20 value in the final comparison.  
 Percentage of the gaps in the final scaffolds. During the de novo assembly, 
many gap regions are introduced into the scaffold sets [Figure 3.3], due to 
use of long insert library. 
Hence, in the following comparison, we mainly focus on these metrics. 
4.3.2 Comparison between de novo assembly and reference-based assembly 
Based on the metrics in section 4.3.1, we compare here our proposed method with 
de novo assembly methods.  
Comparing the assembly results between several stand-alone de novo assembly 
tools---viz, SOAPdenovo [55], Velvet [48], IDBA [54], oases [52], 
SparseAssembler [53], Gossamer [51], ABySS [50]---and several tools which just 
do scaffolding--- viz, Opera [115], SSPACE [116], SOPRA [117]---it is clear that 
SOAPdenovo outperforms other methods on the final scaffold level, especially on 
N50 [Table 4.2 and 4.3]. Hence, for the de novo assembly component in our 
pipeline, due to the larger N50 and longer largest scaffold, SOAPdenovo is adopted 
in this step. However, even for the best results among these several tools, N50 is 
only around 13,000 bp, which means there are still many short scaffolds. Based on 
de novo assembly methods, if we want to improve the assembly results, more insert 
libraries, especially large insert libraries are needed.  
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In order to reduce the cost and take advantage of the released genome sequence of 
another strain of oil palm, we adopt our reference-based genome assembly pipeline 
to improve the results, as described in section 3.2.  
Table 4.2 Comparison between different de novo assembly tools on Contig level 
 Contig level 
method number largest N50 total bases 
SOAPdenovo 31,043,382 60,406 91 2,742,444,815 
AByss 21,671,156 93,899 103 2,192,693,039 
IDBA 1,021,976 51,470 1,582 747,411,128 
Sparseassembler 22,378,344 33,450 88 1,830,152,485 
Velvet 35,672,351 50,472 86 2,821,064,376 
Gossamer No contig level result 
Allpaths-LG Not enough memory 
 
Table 4.3 Comparison between de novo assembly methods and our proposed reference-based method 
 Scaffold level 
 number largest N50 total bases 
SOAPdenovo 1,026,189 270,947 13,984 1,556,659,866 
SOAP+Opera 30,924,876 114,186 91 2,749,023,079 
SOAP+SSPACE 30,338,306 165,586 91 2,741,120,819 
SOAP+SOPRA 28,765,874 184,764 158 267,287,543 
AByss 21,671,129 93,899 2,030 2,192,705,185 
AByss+SSPACE 21,487,200 135,159 103 2,196,888,385 
Abyss+Opera 21,671,156 93,899 103 2,192,693,039 
IDBA 707,194 85,211 3,898 726,160,083 
IDBA+SSPACE 685,306 255,288 3,777 744,070,911 
IDBA+Opera 652,984 327,876 4,239 752,187,646 
IDBA+SOPRA 679,268 297,982 4,031 748,982,674 
SparseAssembler 22,378,344 33,450 88 1,830,152,485 
Sparse+SSPACE 21,960,979 292,071 88 1,831,195,921 
Sparse+Opera 22,678,344 33,874 88 1,836,172,673 
Sparse+SOPRA 21,987,372 34,127 86 1,854,092,132 
Velvet+Oases 11,329,281 135,396 785 1,873,254,194 
Gossamer 20,107,482 127,936 2,673 2,046,871,965 
Allpaths-LG Not enough memory 
Our method 608,380 22,365,697 576,146 2,584,445,363 
Comparing our reference-based assembly results with de novo assembly methods, 
we see that not only N50, but also the longest scaffold, are improved a lot; c.f. Table 




4.3.3 Comparison between ABACAS and our proposed method 
In order to explore the effect of each major component in our final results, we also 
try to compare the result between our proposed reference-based genome assembly 
pipeline with a popular reference-based genome assembly method—ABACAS.  
Comparing with ABACAS, first, the number of scaffolds is reduced by around 
170,000 [Table 4.4]. Another important improvement is that the number of 
scaffolds which can be mapped to the reference genome is improved a lot [Table 
4.4]. This part has largely benefitted from several core components---namely, mis-
assembled scaffold identification, repeat-scaffold identification and overlap-
scaffold identification---in our pipeline, which we will explain in detail in following 
section. 
Table 4.4 Comparison between ABACAS and our method 
  ABACAS Our proposed method 
#scaffold 775,109 608,380 
largest scaffold 22,002,004 22,365,697 
Scaffolds located in 
reference genome 264,600 594,782 
N50 501,301 576,146 
total 2,646,425,608 2,584,445,363 
 
4.3.3.1 Effect of mis-assembly identification component 
Using our mis-assembled scaffold identification method, around 28,585 mis-
assembled scaffolds have been identified [Table 4.5]. After our correction and re-
alignment to the reference genome, around 26,118 (91.2%) can be located in the 
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reference genome again, most of which will be likely incorrectly filtered by 
ABACAS. If these mis-assembled scaffolds were not identified and corrected, 
fewer scaffolds would be connected by the reference genome.  




# scaffold located in reference genome for 
mis-assembly set 26,118 
Therefore, from this comparison, it is important to deal with mis-assembled 
scaffolds in reference-based genome assembly methods, because a lot of mis-
assembled regions are introduced. Otherwise, most of them will be filtered due to 
lower Identity. 
4.3.3.2 Effect of the repeat-scaffold identification component 
After aligning the de novo assembly scaffolds to the reference genome, 45,902 
scaffolds have multiple match locations [Table 4.6], and a total of 127,195 match 
locations in reference genome. Among these 45,902 repeat scaffolds, 27,900 (61%) 
are predicted as potential repeat scaffolds by our method.  
Table 4.6 Statistic for the repeat scaffolds 
#repeat scaffold 
located in reference genome 
45,902 
#total repeat times 127,195 
#potential repeat scaffold by our threshold 27,900 
Considering the huge number of repeat scaffolds, it is not reasonable to randomly 
assign a match location for these repeat scaffolds, as per ABACAS. Hence, it is 
necessary to give a reasonable location for these repeat scaffolds.  
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In summary, we have mentioned in the beginning of this section that the number of 
scaffolds is reduced by around 170,000, and the scaffolds that can be located in the 
reference genome is increased by 330,182, in comparison to ABACAS. Among 
these 330,182 scaffolds, three major components account for this improvement. 
One is the mis-assembly component, which we have explained in section 3.2.4.2. 
Another one is the repeat-scaffold component, which has been shown in section 
3.2.4.4. The other reason is because of overlap scaffold, which has been shown in 
section 3.2.4.5. The percentage distribution is shown in Figure 4.3. 
Figure 4.3 Pie chart of the increased scaffold located in reference genome, comparing to ABACAS 
 
From the comparison between ABACAS and our proposed pipeline, the major 
components in our pipeline have great effect on the final results.  
Benefitting from next-generation sequencing, draft genomes for many species have 
been finished [2, 118, 119]. Afterward, post-processing and revising these draft 
genomes become a challenge. Generally, a little improvement in the assembly can 
save a lot of time and cost in the post-processing step. Therefore, we believe our 
refined reference-based genome assembly pipeline can provide some evidence and 






Due to the advantages for our reference-based genome assembly pipeline, we 
perform downstream analysis using the assembled Dura draft genome produced by 
our proposed pipeline. 
4.4 Evaluation of Dura draft genome 
Before using the Dura draft genome for the downstream analysis, we should first 
evaluate its quality. If the quality is not acceptable, it can cause many errors in the 
downstream analysis. At the same time, we can also use these evaluations to 
compare the accuracy of ABACAS with our reference-based genome assembly 
pipeline. 
Three methods--- viz, EST coverage, completeness of genome and linkage map---
are applied to check the quality, as explained individually in the following sections.  
4.4.1 EST coverage 
A total of 41,695 oil palm expressed sequence tags (ESTs), collected from leaf and 
mesocarp tissues [120], were used to assess the gene coverage of this draft genome 
for oil palm. ESTs were aligned to the genome by BLAT [121], which can handle 
introns in DNA/RNA alignment. Only ESTs with alignment of identity>0.9 were 
retained.  
Our result indicates that the draft genome has a high coverage of protein-coding 
genome regions (~80%); see Table 4.7. In other words, most of the ESTs/cDNAs 
have sequences represented in our draft genome. In addition, we also applied the 




Table 4.7 Statistic result for the EST coverage of the Dura draft genome 
Dataset EST reads Number match number covered by assembly 
mesocarp 
>500 1,126 848 75.31% 
>100 6,514 4,878 74.88% 
>50 10,251 7,782 75.91% 
>10 20,972 16,415 78.27% 
all 33,841 27,034 79.89% 
leaf 
>500 7 5 71.43% 
>100 87 54 62.07% 
>50 216 144 66.67% 
>10 1,893 1,438 75.96% 
all 7,854 6,340 80.72% 
total  41,695 33,374 80.04% 
4.4.2 Completeness of draft genome 
To check the completeness of our draft genome, a computational method CEGMA 
[122] was adopted, which defined a set of very conserved protein families that 
occur in a wide range of eukaryotes. By the conserved proteins defined therein, it 
can measure the completeness of each genome. 
Among the 248 highly conserved proteins defined in CEGMA [122], 87% of them 
can be found in our draft genome. In other words, the result suggests that our draft 
genome uncovers ~87% of oil palm genes. However, for ABACAS, it only 
uncovers ~76% of oil palm genes.  
4.4.3 Linkage map 
Another method to evaluate quality is to use the marker dataset from oil palm and 
examine how many known markers can be found in our draft genome. Usually, 
researchers used markers for germplasm diversity analysis, linkage to monogenic 
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traits of fruit color, shell thickness, and fatty acid composition of the oil [123, 124]. 
In our study, the linkage map can also help us to determine the correctness of each 
scaffold and map the scaffolds into real chromosomes. 
We have already constructed an integrated linkage map consisting of 256 SSR 
markers from Billotte et al. [125] and 454 SSR markers identified by ourselves [Ref 
under review]. These 710 SSR markers were aligned to the draft genome using 
BWA [126] with no more than 1 mismatch. 98.03% of total markers can be 
successfully aligned to our draft genome [Figure 4.4], which is higher than 
ABACAS, with around 91.97% coverage. To some extent, this shows the high 
quality of our draft genome, which is consistent with the measurement in previous 
sections.  




Taken together, the results by three independent methods show the quality and 
completeness of our Dura draft genome. Therefore, this draft genome can be used 
for downstream analysis. In addition, the results also shows that our pipeline 
outperforms the popular reference-based assembly genome method—ABACAS.  
4.5 Annotation of Dura draft genome 
After assembling the Dura draft genome, the next task is annotation of this whole 
draft genome, such as protein-coding gene annotation, repeat annotation and 
noncoding RNA annotation. Without this information, cloning of some specific 
genes and connection between phenotype and genes is difficult. By identifying 
specific gene locus, it can be possible to connect gene, phenotype and function. 
Hence, in this section, we mainly discuss the different annotation for this draft 
genome.  
4.5.1 Repeat annotation 
For repeat annotation of our draft genome, it mainly contains three sources: de novo 
repeat finding, known repeat searching against existing databases and tandem 
repeat searching.  
4.5.1.1 De novo identification of repeat sequence 
RepeatScout [127] was used as the first step in de novo identification of repeat 
sequence in the draft genome. LTR retrotransposons were identified with 
LTR_FINDER [128] with default parameters. All repeat sequences with 
lengths >100bp and gap “N” less than 5% constituted the raw transposable (TE) 
library. Then, an all-versus-all BLASTN (E-value<1e-10) was used to search 
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against the raw transposable element (TE) library, and a sequence was filtered when 
two repeats were aligned with identity >80% and minimal matching length >100bp. 
At the end, a non-redundant TE library was produced. 
4.5.1.2 Identification of known TEs 
RepeatMasker (version 4.0.1) ( http://www.repeatmasker.org/) and the Repbase 
[129] database were used to find TE repeats in the assembled genome. TEs were 
identified both at the DNA and protein level. RepeatMasker was applied for DNA-
level identification and RepeatProteinMasker was used to perform protein-level 
identification. Overlapping TEs were integrated to generate the final known TEs 
library. 
4.5.1.3 Tandem repeats 
Another important repeat family is tandem repeats. Hence, tandem repeats were 
also identified here using TRF [130], with parameters set to “Match=2,  
Mismatch=7, Delta=7, PM=80, PI=10, Minscore=50, and MaxPeriod=12”. The 
same parameters have also been used in other organisms, such as the panda genome 
[97].  
Finally, after combining three repeat libraries, repeat sequences account for 30.28% 
of the draft genome, similar to Oryza sativa (40% ) [118] and Brachypodium (28%) 
[131], but much lower than Zea mays (84%) [108]. Same observation with the 
Oryza sativa [118], Sorghum bicolor [37] and Zea mays [108] genomes, the most 






Table 4.8 Repeat statistics for oil palm draft genome 
class # len(bp) ratio 
Retroelements 129,593 103,475,488 9.80% 
DNA transposons 12,922 6,377,751 4.43% 
Unclassified 1,039 385,351 1.02% 
Satellites 260 62,938 0.00% 
Simple repeats 174,807 12,960,688 0.89% 
Low complexity 891,607 49,884,865 3.40% 
total 1,158,469 163,569,879 19.54% 
Tandem repeat 146,795 10,473,251 0.74% 
unassembled repeats  173,574,126 10.00% 
total repeats  563,569,879 30.28% 
4.5.2 Gene annotation 
4.5.2.1 De novo gene prediction 
In order to improve the gene annotation results, several de novo prediction software 
programs---Augustus [68, 132] with gene model parameters trained on Oryza 
sativa , SNAP [133] and GeneMark-ES [134] with Oryza sativa parameter files---
were used in our study. However, in the final gene sets, partial genes and small 
genes with sequence less than 200bp in length were filtered. These would contain 
much a higher error rate [119].  
4.5.2.2 Evidence-based gene prediction 
To provide more evidence complementary to the de novo annotation, we also 
attempted to integrate other evidences, like protein sequences, EST sequences and 
sequences derived from RNA seq.  
(a) Protein sequence. Protein sequences from Arabidopsis thaliana [135], Oryza 
sativa [118], Vitis vinifera [35], and date palm [119] are used to provide protein 
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domain evidence in our draft genome. The alignment between amino acid 
sequences of protein sequence and those in the draft genome was conducted using 
Exonerate [136].  
(b) EST evidence. Totally, 41,695 EST/cDNA mesocarp and endosperm sequences 
of oil palm and 37,048 mesocarp EST sequences of date palm [120] are used to 
provide protein-coding evidence for the whole draft genome and gene families. 
This serves as the direct evidence for the protein-coding ability of the annotated 
genes. 
(c) RNA seq evidence. Next-generation sequencing techniques have great 
potential to improve annotation quality, owing to their deep coverage and high 
throughput. Here, we collect 24 RNA sequencing samples from mesocarp [1.5, 2.5, 
3.5, 4.5, 5.5 months] and endosperm [1.5, 2.5, 3.5 months] tissues in different 
development time points. For this RNA sequence dataset, Trinity [69] is first used 
to obtain the unique transcripts, which are then aligned to the draft genome to 


















4.5.2.3 Reference gene set 
Finally, the evidence-based and de novo gene sets are merged to form a 
comprehensive and non-redundant reference gene set by MAKER2 [138]. The final 
result is presented in Figure 4.5, which shows that the final annotated genome, and 
has captured the features both from de novo prediction and various evidence.  
Based on this final gene set, we perform a general comparative analysis between 
the genes of oil palm and genes identified from Arabidopsis, Sorghum, rice and 
maize. Oil palm exhibits a high similarity to other species in parameters, such as 
the distribution of gene length, coding sequences (CDS), exon length and intron 
length; c.f. Table 4.9. Of the compared species, only the dicot Arabidopsis is 
obviously different from the other species with respect to gene length and intron 
length. This may be also the difference between dicot and monocot plants.  
Table 4.9 Comparison of oil palm with other plants on gene number, average exon/intron length and other 
parameters. Gene density: the number of gene per 10kb 
 sorghum maize rice Arabidopsis oil palm 
gene number 27,640 32,540 34,792 25,498 36,015 
average length 2,873 3,757 3,039 2,011 3,573 
gene density 24 13.1 11 4.5 49.9 
average exon per gene 4.7 5.3 3.7 5.2 3.8 
average exon len 268 304 256 250 217 
average intron len 436 516 409 168 522 
4.5.2.4 Gene function annotation 
For the final reference gene set, function annotation is also necessary for biological 
research. Commonly, function annotation is assigned by homology search in other 
species.  
In our study, the function for each gene was assigned using BLAST2GO [139], 
which attempted to find significant BLAST similarity to proteins from other 
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organisms in the non-redundant (NR) database at the National Center for 
Biotechnology Information (NCBI). However, in the NR database, a lot of proteins 
are annotated with “predicted protein” or “conserved hypothetical protein”. Hence, 
in order to improve the annotation quality and reduce the effect of these missing 
annotation in the NR database, homology search using Arabidopsis thaliana, Oryza 
sativa, and Vitis vinifera protein databases is also provided for our reference gene 
sets.  
The species which has the highest homology with our Dura sample is Vitis vinifera 
[Figure 4.6], a eudicotyledonous crop, followed by another monocotyledonous crop 
Oryza sativa. This high protein sequence similarity between the two less 
phylogenetically related plants (the monocotyledonous oil palm and 
eudicotyledonous grapevine) has been also observed by others, such as the date 
palm [119] and oil palm ESTs [140]. One possible reason may be owing to the 
completeness of Vitis genome and the higher gene number for Vitis. To explain this 
observation and detailed mechanism, additional studies are required. 




4.5.3 NcRNA annotation 
Noncoding RNAs (ncRNAs) are transcripts that are not translated to proteins but 
act as functional RNAs. Several well-known ncRNAs such as transfer RNAs 
(tRNAs) or ribosomal RNAs (rRNAs) can be found throughout the tree of life. 
Fulfilling central functions in the cell, these ncRNAs have been studied for a long 
time [141]. 
However, over the past years, a few key discoveries have shown that ncRNAs have 
a much richer functional spectrum than anticipated. The discovery of microRNAs 
(miRNAs) and short interfering RNAs (siRNAs) change our view of how genes are 
regulated. They play important roles in biological systems of eukaryotes by 
suppressing expression of target genes at the transcriptional and/or post-
transcriptional level. Another surprising observation revealed by high-throughput 
methods is that, in human, 90% of the genome is transcribed at some time in some 
tissues. 
Hence, besides the gene annotation for the draft genome, various ncRNA 
annotations are also performed in our study.  
4.5.3.1 Identification of tRNAs 
A transfer RNA (tRNA) is an adaptor molecule composed of RNA, typically 73 to 
94 nucleotides in length, that serves as the physical link between the nucleotide 
sequence of nucleic acids (DNA and RNA) and the amino acid sequence of proteins. 
Knowing the tRNA repertoire of an organism is important because it affects the 
codon bias seen in highly expressed protein-coding genes. 
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Based on homolog search and secondary structure restriction, several tRNA 
identification software have been developed [142-144]. Among them, tRNAScan-
SE [145] with default parameters has been successfully applied to predict tRNA 
genes in Arabidopsis, sorghum, maize, rice and date palm genome. Hence, we also 
use the same tool on our oil palm draft genome. Finally, our oil palm sample has a 
total of 622 predicted tRNAs, similar to 699 for Arabidopsis [146] and 606 for 
sorghum, suggesting that most of the oil palm tRNAs have been found; c.f. Table 
4.10. It is interesting that 1 tRNA for Selenocysteine is detected in the oil palm 
genome, which has been only found in maize, sorghum and bamboo [96], but not 
in Oryza sativa, Arabidopsis thaliana and even the nearest species, date palm. The 
specific function for this tRNA needs further investigation. 
Table 4.10 Compare oil palm with other plants on different class of tRNAs 
 Z.ma O.sa S.bi P.he A.th Date.P Oil.P 
tRNAs decoding Standard 20AA 1,413 720 535 1,076 685 399 571 
Selenocysteine tRNAs (TCA) 4 0 1 6 0 0 1 
Possible suppressor tRNAs 
(CTA,TTA) 




14 0 8 2 1 3 1 
Predicted pseudogenes 768 26 61 82 13 43 49 
total tRNAs 2,206 746 606 1,167 699 445 622 
4.5.3.2 Identification of rRNAs 
Ribosomes are the molecular machines which form the connection between nucleic 
acids and proteins in all living organisms. The ribosomes dependence on ribosomal 
RNAs (rRNAs) for their function has caused them to be conserved at both the 
sequence and the structure level. Because of this, rRNAs are often used in 
comparative studies such as phylogenetic inference. 
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Commonly, rRNAs are often located by sequence similarity searches such as 
BLAST, due to the high level of sequence conservation in the core regions of the 
rRNA. The validity of the search results depends on the program and database used. 
Hence, we attempt to extract all the rRNAs from the Rfam database, which is the 
most comprehensive database for ncRNA. The rRNA fragments are identified by 
aligning the rRNA template sequences (Rfam [147] database, release 11.0) of 
Arabidopsis thaliana, Oryza Sativa, Sorghum bicolor, Zea mays, Vitis vinifera and 
several other plants using BLASTN with E-value at le-10, and identity cutoff at 90% 
or more. From the results shown in Table 4.11, we see that 1,182 rRNAs are found 
in the draft genome. 
Table 4.11 Overview information of ncRNAs on oil palm draft genome 




verification % of 
genome 
tRNA 636 76 47,240 303 0.00262% 
rRNA 1,182 166 195,316 521 0.00465% 
SnoRNA    164  
C/D box 139 169.5 23,555  0.0246% 
H/ACA 124 102.5 12,710  0.0002% 
snRNA 262 102.67 26,899 47 0.0009% 
Known 
miRNA 
199 127 181,979 100 0.0145% 
Novel 
miRNA 
81 107.7 8,727  0.000005% 
4.5.3.3 Identification of other small ncRNAs 
Except tRNAs/rRNAs, some other types of small ncRNAs also have some specific 
function for each species, such as snRNAs playing roles of processing of pre-
mRNA, miRNAs and snoRNAs. Therefore, we also try to annotate them in the draft 
genome. The following are the methods we used to identify these small ncRNAs. 
The snRNA genes are predicted using INFERNAL [148] against the Rfam database 
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(release 11.0). In order to accelerate the speed, we performed a rough filtering prior 
to INFERNAL; by BLASTN against the Rfam database under E-value 0.01.  
For the prediction of known miRNAs, we first aligned the mature miRNA 
sequences of Arabidopsis thaliana/lyrata, Brachypodium distachyon, Medicago 
truncatula, Nicotiana tabacum, Oryza sativa, Sorghum bicolor, Vitis vinifera and 
Zea mays from the miRBase [149] (release 19) using MiRcheck [150] against the 
draft genome, allowing only one mismatch. The potential to form secondary 
structures by these miRNA candidates with their flanking region is checked later 
by RNAfold [151]. In order to identify novel miRNA for oil palm, RNA samples 
from flower (female and male), pollen, root, kernel (2.5 month) and mesocarp 
(1.5,2.5,3.5,4.5,5.5 months) are also collected for smRNA sequencing. First, rRNA-, 
tRNA- and known miRNA-related reads are removed. Then, regions having match 
reads, and flanking regions in the draft genome, are selected for novel miRNA 
prediction. If any of these regions and flanking regions can form a potential 
secondary structure, it is considered to be a potential novel miRNA. The remaining 
loci with small-RNA read hits, are used to predict novel miRNAs. Similar to known 
miRNA prediction, their flanking regions in these loci are also checked to see 
whether they can form potential hairpin loop structures.  
The C/D snoRNAs are predicted using snoScan [145] with the yeast rRNA 18 and 
25 methylation site and yeast rRNA sequences provided by the snoScan distribution. 
The minimum cutoff score is based on the default settings with 30 bits. Similarly, 
H/ACA snoRNAs are detected by snoGPS [152] using the yeast score tables and 
target pseudouridines; c.f. Table 4.11.  
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Table 4.11 lists all the predicted non-coding RNA genes in the draft oil palm 
genome. Among them, 199 known miRNA families have been identified; around 
50% of them have been verified by our smRNA sequencing data for oil palm.  
4.5.3.4 Identification of long intergenic noncoding RNA (lincRNA) 
Long noncoding RNAs (lncRNA) are transcribed RNA molecules greater than 200 
nucleotides in length. Based on their location in the genome, they are further 
divided into: (i) long intergenic noncoding RNAs (lincRNAs); (ii) long intronic 
noncoding RNAs (incRNAs); and (iii) natural antisense transcripts (NATs). 
Genomes of human, mouse and fly have been shown to encode lncRNAs that play 
important roles in cell differentiation, immune response, imprinting, tumor genesis 
and other important biological processes [85, 153]; besides, genetic mutations of 
human lncRNAs have been shown to be associated with diseases and 
pathophysiological conditions [154]. For plants, genome-wide search for ncRNAs 
has been previously conducted in Arabidopsis thaliana [5], Medicago truncatula 
[155], Zea mays [156] and Tritucum aestivum [157]. These lncRNAs show tissue-
specific expression, and a large number of them are responsive to abiotic stresses. 
However, the function of these lncRNAs remains largely unexplored. Genomic loci 
of many lncRNAs are associated with histone modifications and DNA methylations 
suggesting an epigenetic regulation of these loci [158].  
Hence, considering their important functions in the whole genome, we also attempt 
to identify and annotate lncRNAs in our Dura draft genome. The pipeline is similar 
to that of our previous work on Arabidopsis thaliana [5].  Due to the non-strand-
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specific sequencing for our datasets, only long intergenic RNAs (lincRNAs) are 
considered in our study here. 
Figure 4.7 Pipeline for identification of long intergenic noncoding RNA 
 
In general, all intergenic transcripts which can be transcribed can be considered as 
potential lincRNAs; however, some of them may also be related to other types of 
transcripts, such as truncated mRNAs, by-products of protein-coding genes, 
expressed repeats, or others. Such transcripts may confound the analysis of bona 
fide lincRNAs. Therefore, to facilitate further investigation of lincRNAs, we use 
the following criteria to provide a strict definition for lincRNAs for our oil palm 
sample:  
(1) The transcript length must be at least 200 nucleotides;  
(2) The transcript must contain no open reading frame (ORF) encoding >100 amino 
acids;  
(3) The transcripts encoding lincRNAs must be located at least 500 bp away from 
any known protein-coding genes and genes for housekeeping ncRNAs;  
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(4) The transcripts must not encode any transposable elements (TEs); 
Based on these features, to identify lincRNAs in our Dura genome, we subjected 
29 RNA libraries derived from mesocarp, endosperm, root, leaf, flower and pollen 
to RNA-seq. Each RNA library yields around 20 million 101bp pair-end sequences; 
c.f. Figure 4.7. The total number of sequencing reads approaching 1 billion is 
comparable to or even higher than those reported by several RNA-seq studies in 
other species. The detail process for the identification can be summarized as: 
First, these RNA sequence reads are aligned to our draft genome using Tophat [159, 
160] and SAMtools [161]. The mapped sequences are then assembled into 
transcripts using Cufflinks [160] and Cuffcompare, yielding 13,204 to 27,434 
transcripts in each organ. Of these, 10,524 to 21,715 transcripts (80%) are mapped 
to the genomic regions of annotated oil palm transcripts; c.f. Table 4.9. The 
remaining transcripts, using Cuffcompare, derived from intergenic regions are 
merged into 4,181 transcripts, which are potential lincRNA candidates.  
Furthermore, by restricting the distance to annotated genes and length of the 
transcripts, around 3,000 lincRNAs are identified at the end. 
The whole pipeline for this process is summarized in Figure 4.7. The detail number 
of lincRNA on each tissue is presented in Table 4.12, which shows that pollen tissue 





Table 4.12 Statistic information for the gene, lincRNA and miRNA identified by RNA seq data set 
tissue gene gene_RNAseq gene_repeat miRNA lincRNA lincRNA_repeat 
KD1.5 7,555 1,890 14,139 21 1,353 1,847 
KD2.5 7,407 1,808 14,237 28 1,523 1,935 
KD3.5 6,120 1,434 12,526 24 1,301 1,693 
MD1.5 7,163 1,912 13,833 26 1,375 1,835 
MD2.5 7,165 1,845 13,806 28 1,381 1,851 
MD3.5 6,814 1,803 13,347 23 1,305 1,816 
MD4.5 6,584 1,839 13,527 34 2,367 2,212 
MD5.5 6,862 1,898 13,595 40 2,622 2,417 
Leaf 7,164 1,899 13,568 27 1,436 1,916 
MF1 5,991 1,527 12,176 22 1,352 1,785 
MF2 6,962 1,832 13,285 24 1,629 2,008 
FF1 6,136 1,505 12,373 25 1,190 1,695 
FF2 6,075 1,451 11,959 23 1,061 1,618 
Pollen 3,416 830 7093 15 822 1,028 
Next, by comparing the expression level between protein coding genes, pri-
miRNAs and lincRNAs in Figure 4.8, we see that the expression level of lincRNAs 
is lower than protein coding genes, but a little higher than pri-miRNAs. These 
results suggest that lincRNAs may differ from mRNAs in their biogenesis, 
processing, and/or stability. Moreover, the relatively low expression level suggests 
that very few of them are detected by cDNA/EST library. 
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Figure 4.8 Expression level of protein coding gene, pre-miRNA and lincRNA 
 
4.6 Gene family for fatty acid pathway 
Oil palm is a highly efficient oil-producing crop. The detail mechanism is still 
unknown. Thus, after constructing the Dura draft genome, it is interesting to 
investigate genes involved in lipid biosynthesis pathways (Table 4.13) and do 
comparative studies between different species (Arabidopsis thaliana, date palm, 
Vitis vinifera, Glycine max and Oryza sativa).  
We have summarized all the genes related to lipid biosynthesis pathways from 
different species in Table 4.13. These results show that oil palm and soybean have 
the highest copy number for lipid-pathway genes, which may explain why these 
two species accumulate the highest amount of fruit/seed oil. In addition, oil palm 
has more FAD genes than soybean, which are responsible for transferring oleic acid 
to palmitic acid. Although the detail relationship between these family members is 
still unknown, we believe that the huge number of lipid-related genes in oil palm 
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and soybean can play different roles related to lipid synthesis under various 
conditions. 
Table 4.13 The number of genes in fatty acid biosynthesis pathways for each plants 
 Arabidopsis oil palm date palm Vitis soybean rice 
ACC 1 6 3 3 4 0 
DGAT 1 4 3 2 5 2 
EAR 0 7 3 0 8 4 
FAD 2 11 1 0 0 0 
FAT 0 11 4 5 12 6 
GPAT 10 7 0 6 28 24 
HAD 2 3 0 1 4 6 
KAR 1 5 2 4 4 10 
KAS 27 49 21 27 51 32 
LACS 0 3 3 5 13 5 
LPAAT 0 4 1 0 0 0 
MAT 1 2 2 1 2 1 
PAP 0 3 2 0 0 0 
PDAT 1 6 0 2 4 1 
PDH 4 17 17 6 14 5 
PK 0 31 19 14 30 10 
SAD 7 8 5 10 5 9 
total 57 177 86 86 184 115 
 
4.7 Homologous genes 
Comparative homolog analysis, including date palm [119], Vitis vinifera [35] and 
Oryza sativa [118], suggests that there are around 36,015 protein-coding genes in 
oil palm, with 12,190 protein-coding genes being shared by date palm, Vitis and 
rice; see Figure 4.9. Among them, date palm shares the most number of homologs 
(4,898) with oil palm, much more than the 408 with rice, 398 with grape (Vitis). 
This is consistent with their close evolutionary relationship.  
In addition, there are 10,463 unique protein-coding genes in oil palm; some are 
potentially employed in important biological processes (for example, the control of 
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flowering time or secondary metabolisms).  
Figure 4.9 Venn graph of homologs between oil palm, date palm, Vitis and rice 
 
4.8 Whole-genome duplication 
Genome-wide duplication in angiosperms is common, and represents an important 
molecular mechanism that has shaped modern plant karyotypes.  
To generate a pair-wise alignment of gene models between oil palm and Vitis, oil 
palm and soybean, oil palm and date palm, all predicted genes are aligned to the 
reference genes by Mummer [101]. The criterion is that the number of genes in one 
synteny block should be more than 5. In order to clearly visualize these synteny 
blocks, we just selected the 10 longest chromosomes from Vitis and rice, and the 20 
longest scaffolds from date palm and oil palm.  
Each homolog is shown as a black dot, while a synteny region is represented in a 
rectangle in Figure 4.12. From this figure, we can see the conservation regions 
between oil palm and the species mentioned, which shows that soybean shares more 
conservation regions than the other two plant species. Similar results can be found 
in Figure 4.10.  
One possible reason for this phenomenon is that the annotation of the soybean 
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genome is much better and the top 10 chromosomes of the soybean genome are 
much longer than others, especially date palm.  
Figure 4.10 a: synteny region between oil palm and soybean b: synteny region between oil palm and Vitis 
 
Under a circle view for these synteny regions, it is clear that the synteny regions 
between Vitis and oil palm are located in chromosome 1 of Vitis, detail synteny 
locations for these two chromosomes are shown in Figure 4.11. 





Figure 4.12 The synteny region in the detail location of each chromosome. a Synteny region between oil 
palm and date palm  b Synteny region between soybean and oil palm c Synteny region between oil palm 
and Vitis 
 
4.9 Evolution history of oil palm 
Due to the difficulty of constructing transgenic oil palm, the rapid growth of oil 
yield has been stimulated in major part by progress in research and development 
(R&D). Discovery of the single-gene inheritance for shell thickness and subsequent 
adoption of D X P planting materials has led to a quantum leap in oil-to-bunch ratio 
from 16% (Dura) to 26% (Tenera). Thus oil palm cultivation becomes more 
profitable.  
Further yield improvements have subsequently been made through breeding for 
Dura and Pisifera with specific combining ability. During the past thirty years, 
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modern breeding methods based on quantitative genetics theory have been 
extremely successful in improving oil productivity. Hence, in our study, based on 
our draft genome, we also attempt to identify the most common alleles at the 
majority of polymorphic sites in the genome and provide some evidence and 
suggestion for future breeding.  
Benefitting from next-generation sequencing, a wide range of genetic and 
archaeological studies have been carried out to examine the phylogenetic 
relationship with other species, like rice [162]. Molecular genetic analyses 
indicated that indica and japonica originated independently. Meanwhile, 
population genetics analyses of genome-wide data of cultivated and wild rice have 
also tended to suggest that indica and japonica genomes generally appear to be of 
independent origin [3]. Despite these advances in other species, there is still a lack 
of clarity of the evolutionary history of oil palm domestication by population-scale 
whole-genome sequencing. An in-depth investigation of the haplotype structure 
near the domestication sites is critical for evaluating the direction of introgression. 
Moreover, a comprehensive map of oil palm genome variations can facilitate 









Table 4.14 Description of 12 oil palm strains 
Sample Origin-species coverage 
TS1 AVROS-pisifera 2.86 
TS2 EKONA-pisifira 2.82 
TS3 GHANA-pisifera 3.14 
Dura A Asian-Dura 3.04 
Com1 DeLi1 Com1 DeLi1-Tenera 2.57 
Malaysia 08 Malaysia 08-Tenera 3.47 
LT2O3 LT2O3-Tenera 3.37 
T2BIS2 T2BIS2-Tenera 2.83 
Com NiG 02 Com NiG 02-Tenera 3.44 
Com Gha 04 Com Gha 04-Tenera 3.04 
Dura B Dura B (Asia)-Dura 3.09 
AGO T 08g AGO T 08g-Tenera 3.69 
Hence, after constructing the draft genome for Dura, we also collect diverse oil 
palm strains from the whole world for sequencing and attempt to carry out genome-
wide association studies for many agronomic traits in oil palm evolutionary history.  
From the large collection of oil palm in the world, we select 3 categories including 
12 different strains mainly from Asia and African, spanning the native geographic 
range of the species; c.f. Table 4.14. From the coverage of each sample, it can be 
found that the sequencing depths for whole genome is around 2-3 fold. 
4.9.1 Overview of diversity for oil palm 
In order to find SNPs between these oil palm strains with our draft genome, the pair 
end reads of all the samples are first aligned against our draft Dura genome. After 
alignment, SNPs between our reference genome and other oil palm strains are 
called by SAMtools [161], c.f. Table 4.15. By comparing the number of SNPs with 
the reference genome, it is found that DuraA, DuraB and Malaysia shares little 
SNPs with other species, which is consistent with the fact that all of them are from 
 84 
 
Asian countries.  













In order to explore various information of SNP for oil palm, we compare the 
following information for different groups [Figure 4.13]. 
a. location information for each SNP: Intergenic region, UTR, intron, exon, CDS, 
downstream (length: 5Kb), upstream (length 5Kb). 
b. coding feature: NON_Synonymous_coding (SNP causes a codon that produces 
a different amino acids), Synonymous_coding (SNP causes a codon that produces 
the same amino acid). 
c. codon level: Codon_change (one or many codons are changed), Codon_Insert 
(One or many codons are inserted), Codon_deletion (one or many codons are 
deleted), Exon_deleted (A deletion removes the whole exon), Start_Lost (start 
codon is mutated into a non-start codon), Synonymous_start (start codon is mutated 
into another start codon), Synonymous_stop (stop codon is mutated into another 
stop codon), Stop_lost (stop codon is mutated into a non-stop codon). 















Figure 4.13 Statistic for different SNP categories of oil palm 
 
From the distribution for the SNP numbers in all categories [Figure 4.13], we find 
that most (72%) are located in intergenic regions, and only a few of them are located 
in coding sequence regions. Among the latter, there are 110,446 nonsynonymous 
SNPs and 81,774 synonymous SNPs. Thus the ratio of nonsynonymous-to-
synonymous substitutions is 1.35, which is similar to rice genome (1.29) [3], higher 
than Arabidopsis (0.83) [163] and lower than soybean (1.61) [4]. In addition, we 
have also identified more than 1,000 stop or start codon change-related protein 
coding genes. As for the biological reason behind these start/stop codon mutations, 
it needs more detail exploration of these genes.  
4.9.2 Structure and population analysis for oil palm 
Based on SNP data, we next investigated the population structure of these oil palm 
strains to understand their evolutionary relationship. On the basis of the neighbor-
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joining tree, Figure 4.14.a, same with our observation by SNP number, DuraA/B 
and Malaysia are the nearest neighbors to our reference genome, which are totally 
different from the Pisifera group. For the Tenera group, it displays some divergent 
phenomenon, different from Pisifera/Dura group. This evolution tree provides us a 
good clue to select crossing species for breeding. The further from the reference 
strain, the more chance of getting a good crossing outcome, because there is more 
possibility to get a genome recombination.  
Figure 4.14 Population genetic analysis of oil palm a: neighbor-joining tree for 12 different oil palm strains 
b: PCA result for 12 different oil palm strains c: Bayesian clustering (STRUCTURE, K=3) d:iHS score for 
different diversity sites across all chromosomes 
 
Similar results can also be obtained from principal component analysis (PCA) 
analysis, which shows that DuraA, DuraB and Malaysia are the nearest; c.f. Figure 
4.14.b. Interestingly, the Tenera group is classified into several groups. That may 
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be because Tenera are crosses between Dura and Pisifera group, some of them may 
be similar with maternal line, whereas some of them may be similar with the 
paternal line, and others may have their own features. These results are also 
supported by the Bayesian clustering program STRUCTURE [164], with K=3 
[Figure 4.14.c]. 
Nucleotide diversity is a common measure of genetic variation. It is usually 
associated with other statistical measures of population diversity, and is similar to 
expected heterozygosity. This statistic may be used to monitor diversity within or 
between ecological populations, to examine the genetic variation in crops and 
related species or to determine evolutionary relationships. The integrated haplotype 
score (iHS) is a measure of the amount of extended haplotype homozygosity (EHH) 
at a given SNP along the ancestral allele relative to the derived allele. This measure 
was designed by Voight et al as a method to describe a recent map of positive 
selection in the human genome [165]. In our study, the iHS score across the whole 












Figure 4.15 Enriched GO terms for high-diversity gene locus Orange: biological process Green: cellular 
component Blue: Molecular function 
 
After selecting high- and low-diversity locus using iHS score, by GO term 
enrichment for these high- and low-diversity genes, we find that gene families with 
essential functions (for example, translation, maintenance of protein location in 
nucleus) tend to have substantially lower substitution ratios [Figure 4.16], whereas 
gene families that function in regulatory processes, such as fatty acid metabolic 









Figure 4.16 Enriched GO terms for low-diversity gene locus Orange: biological process Green: cellular 
component Blue: Molecular function 
 
In summary, we provide new insights into how oil palm strains evolved by SNP 
analysis. We will further investigate the relationship between these SNP-based 
markers and genotypes of oil palm, which can guide future breeding efforts.  
 












Figure 4.17 Global overview about chromosome of oil palm   a: chromosome information b: iHS score 
distribution c: gene density d: repeat density e: segmental duplication in genome 
 
4.10 Conclusion 
In this chapter, we have applied our proposed reference-based genome assembly 
pipeline to genome sequencing data of Dura oil palm. From the results on our Dura 
sample, it is clear that our pipeline outperforms de novo assembly methods and 
other reference-based methods (ABACAS).  
Evaluation from three independent methods---EST coverage, genome 
completeness and linkage map---has demonstrated the accuracy and completeness 
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of our draft Dura genome. This is the first complete genome sequence for Dura, 
and is the second complete genome sequence for oil palm. Our draft genome can 
be used for downstream analysis.  
Based on this draft genome, gene annotation, ncRNA annotation and lincRNA 
annotation are performed. This draft genome encodes around 30,000 protein-
coding genes, 200 miRNAs and 1,000 lincRNAs. These annotations should 
facilitate research on oil palm.  
By the statistics information of lipid-related genes and comparison with other oil 
crops, we also get a general overview of possible reasons for the high oil yield of 
oil palm. 
By resequencing of 12 different oil palm strains, we have obtained a clearer 
overview of the evolutionary history of the oil palm family. The result provides 
some evidence and suggestion for improvement of oil palm by cross-breeding.  
In summary, we believe our results provide a rich genome resource for molecular 









VISUALIZATION OF VARIOUS GENOME INFORMATION 
To provide convenient access and query for the research community, especially 
biologists, we have built several visualization tools for various genome information. 
Based on the characteristics of various genome information, our database aims to 
provide the following 5 essential functions: (1) Visualization of location and 
structure information for each transcription units, such as protein-coding gene, 
miRNA and long noncoding RNA; (2) Expression levels from various source, such 
as RNA-seq, tilling array and Chip-seq; (3) Epigenetic modifications information 
(e.g. DNA methylations and histone modifications) across genomic regions; (4) A 
collection of siRNA sequencing dataset across the whole genome; and (5) BLAST 
function to support homolog search. 
Therefore, we integrated all the genome information of Dura oil palm into our 
GBrowse-based platform that was used for another long noncoding RNA database 
[PLncDB][137]. Here, we explain these functions in detail in following sections. 
5.1 An online database to deposit, browse and download genome element 
We constructed a database [Figure 5.1] using the open source GBrowse library [166] 
to integrate and visualize different sources, such as protein coding gene, small 
ncRNA and lincRNA annotations. In addition, a list of de novo gene prediction 
results from Augustus [68], SNAP [133] and Tophat [160] and final gene model 
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integrated from Maker 2 [138] can also be visualized [Figure 4.5]. As for expression 
information, we adopted a new file format BigWig [167] similar to BAM, which is 
binary, compressed and reduces loading time to the browse. The database can be 
accessed or queried in various ways. Specific searches can be performed using the 
name/keywords of gene/protein and/or location on the chromosome. At the same 
time the entire database is available for download in different formats.  
Figure 5.1 Snapshot of the GBrowse database to visualize the genome element 
 
5.2 Visualizing detail information for transcript unit 
Just by clicking on a specific item, researchers can visualize mutant/stress related 
information; see Figure 5.2. By viewing these detail information, researchers can 
obtain potential function of genes, according to the relative expression level in each 
tissue. By experimental verification, biologist can conduct further mechanisms-




Figure 5.2 An example of detail information for transcript unit in the database 
 
5.3 Visualizing relative expression level across the whole genome 
Besides the location information, we also provide the relative gene expression level 
for the whole genome. The expression level is measured by RNA sequencing 
technique, Chip-seq and array platform, which divides the whole genome into equal 
small window sizes [Figure 5.3]. By this method, the user can have a clear view 
about the activity and epigenetic information for the whole genome, even the 
intron/exon difference. Like the example in Figure 5.3, we can see that this protein 
coding gene is highly up-regulated under salt, drought and ABA treatment, which 
means this gene may have specific functions for abiotic stresses.  
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Figure 5.3 Snapshot for the expression level of our database 
 
5.4 Visualizing smRNA abundance across the whole genome 
Noncoding RNAs such as ribosomal RNAs, transfer RNAs, small nuclear RNAs, 
small nuclear RNAs, and small interfering RNAs, can serve catalytic and 
scaffolding functions in transcription, messenger RNA processing, translation, and 
RNA degradation [152]. Besides the location for various ncNRA families, we also 
provide the expression level for all these ncRNAs based on our smRNA sequencing 
datasets [Figure 5.3]. In this case, miRNAs related to different conditions/mutants 
can be easily found and queried. Moreover, combined with epigenetic information 
in the whole genome, it is even possible to find some siRNA-medidated epigenetic 
silence locus.  
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5.5  BLAST tool 
Another requirement and use of our genome resource is homology search by 
sequences from other species. Therefore, in addition to GBrowse-based tool for 
visualizing oil palm genome information, we also support BLAST function for any 
given query sequence [Figure 5.4].  
For this BLAST tool, we have enabled querying using any nucleotide and peptide 
sequences. At the same time, user also can conduct nucleotide-level homolog 
search and protein-level homolog search by selecting BLASTN, BLASTP, 
BLASTX, etc.  





In this chapter, two useful tools---a GBrowse-based database and a BLAST tool---
have been developed. Using these two tools, people, especially biologists can easily 
guess the potential function for specific genes and design experiments to verify 
















WEIGHTED PATHWAY APPROACH 
Different from primary metabolites, secondary metabolites are another important 
group for plants. Although they do not play essential functions, like lipids as one of 
the sources of energy, they typically mediate interactions of plants with other 
organisms. These interactions include those of plant-pollinators, plant-pathogens 
and plant-herbivores. Although these interactions are not necessary for the basic 
life of plants, they are very useful between plants and the environment.  
Figure 6.1 Simplified schematic overview of the biosynthesis of the main secondary metabolites stored 
and/or secreted by glandular trichome cells. Major pathway names are shown in red, key enzymes or 
enzyme complexes in purple, and stored and/or secreted compounds in blue. [168] 
 
Commonly, secondary metabolites can be classified based on their chemical 
structures (for example, having rings, containing a sugar), compositions (containing 
nitrogen or not), their solubility in various solvents, or the pathways by which they 
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are synthesized (e.g., phenylpropanoid, which produces tannins) [168]. A simple 
classification includes three main groups: Terpenes (made from mevalonic acid, 
composed almost entirely of carbon and hydrogen), phenolics (made from simple 
sugars, containing benzene rings, hydrogen, and oxygen), and nitrogen-containing 
compounds (extremely diverse, may also contain sulfur) [Figure 6.1].  
Most of these secondary metabolites are produced by hair-like epidermal structures, 
commonly referred to as trichomes if they are present on the aerial parts [Figure 
6.2]. Trichomes can be single-celled or multicellular, but the criterion that is most 
commonly used to classify them is whether they are glandular or not [168]. For the 
model plant Arabidopsis, only non-glandular trichomes can be found, which are 
unicellular and can be either unbranched, or has two or five branches [169]. These 
trichomes are polyploid and have been extensively studied with respect to their 
development [170]. However, large amounts of secondary metabolites are usually 
produced by glandular trichomes, which can be found on approximately 30% of all 
vascular plants.  
Secondary chemicals of plants have important uses for humans. Most 
pharmaceuticals are based on plant chemical structures, and secondary metabolites 
are widely used for recreation and stimulation (the alkaloids nicotine and cocaine, 
the terpene cannabinol). The study of such plant use is called ethnopharmacology. 
Psychoactive plant chemicals are central to some religions, and flavors of 
secondary compounds shape our food preferences. The characteristic flavors and 
aroma of cabbage and relatives are caused by nitrogen-and sulfur-containing 
chemicals, glucosinolates, which protect these plants from many enemies [1]. The 
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astringency of wine and chocolate are derived from tannins.  
Figure 6.2 Glandular trichomes in section Lycopersicon. [168] 
 
Despite the large commercial application of secondary metabolites, many of them 
are still harvested naturally. The accumulation of these specialized metabolites in 
plants is low and depends on environmental factors. Access to such compounds is 
often inadequate, and the reliance on the production of metabolites from naturally-
growing plants is not always sustainable. Hence, in this chapter, we introduce a 
weighted pathway approach to investigate secondary metabolisms by next-




To investigate the detail mechanism for these secondary metabolisms, the first 
problem is that of identifying or detecting secondary metabolisms and the 
associated protein-coding genes and metabolites. Only recently the monitoring of 
metabolites has grown into an ‘omics’ level field [171]. Gas chromatograph-mass 
spectrometry (GC-MS) has been applied to examine the effects of genetic and 
environmental manipulations [172], to determine phloem composition [173]. GC-
MS is currently the most developed of the available analytical tools for metabolites. 
The growth of this technology offers an opportunity to view the effect of elicitation 
on metabolism at a larger scale than previously possible. However, GC-MS 
technique can only detect the relative expression level of different secondary 
metabolites. It is still unknown how to improve the yield of these secondary 
metabolites.  
At the beginning, new metabolites are often discovered by homology-based cloning 
of genes involved in their biosynthesis [12, 13]. More than a decade ago, DNA 
microarrays have provided scientists the capacity to simultaneously investigate 
thousands of features in a single experiment. This capability has been exploited not 
only to monitor the steady-state expression of genes, but also to map the genome-
wide binding sites of DNA interacting proteins (ChIP-on-chip) and to survey long-
range DNA interactions (4C). The over-whelming wealth of knowledge generated 
by microarrays has created entirely new fields of research and, as the underlying 
technology became broadly adopted, microarrays forever changed the way in which 
high-throughput science is done. 
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However, because of the lack of extensive genomic data for the vast majority of 
plants, especially plants which are the major secondary metabolite producers, it is 
difficult to use the common microarray-based approach for transcriptome analysis. 
This is because such an approach requires prior designed probes for each target. 
The limitation of its prior requirement hinders its applications, especially for plants 
producing secondary metabolites.  
Equally revolutionary technologies are currently emerging in the form of new 
methods of sequencing, termed massively parallel sequencing (MPS, also called 
next-generation/ultra-high-throughput sequencing). With the development of this 
technique, new genes/specific transcripts can be discovered and analyzed in a 
genome-wide model [14, 15], even without a reference genome. 
Using transcriptome data produced by next-generation sequencing techniques, 
some interesting gene candidates can be identified by differential expression 
analysis between different conditions/tissues. However, for many investigators, the 
list of differentially expressed genes often fails to provide mechanistic insights into 
the underlying biology of the condition being studied [174]. In addition, people are 
also interested in new functions or compounds. Most previous studies, involving 
next-generation sequencing data, have just focused on the known secondary 
metabolisms to identify bottlenecks in known biosynthesis pathways [175-177]. 
Thus, in this way, the advent of high-throughput sequencing technologies presents 
a new challenge, that of predicting new functions or new metabolites for plant 
samples. For several years ago, there has been a paradigm shift from individual 
genes to gene sets [Figure 6.3]. Each of these gene sets performs a specific function. 
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These methods can be classified and summarized into the categories below.  
Figure 6.3 Analysis methods for RNA-seq data 
 
6.1.1 Co-regulated genes 
One approach to this challenge has been to construct co-expression networks [178, 
179]. From these networks, some genes that are co-expressed with known 
proteins/metabolites in known biosynthesis pathways of some secondary 
metabolites are extracted. These genes are hypothesized to play important roles in 
the biosynthesis of those secondary metabolites [71]. However, most of these works 
just use some traditional statistical methods to identify co-expression pairs, and the 
resulting accuracy is very limited [180, 181]. In addition, most of these studies lack 
experimental results that verify or support the predictions and conclusions, 
especially for non-model plants.  
6.1.2 Over-representation analysis (ORA) 
In the past decade, researchers have developed a large number of knowledge bases 
to help to understand the transcriptome at functional level. The knowledge 
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describes---using the standardized nomenclature of GO terms---the biological 
processes, components, and molecular functions in which individual genes and 
proteins are known to be involved in, as well as---using the not-so-standardized 
nomenclature of biological pathways---how and where gene products interact with 
each other. This allows the analysis of RNA-seq data at the functional level.  
Using GO term and pathway datasets, some people have tried to identify active 
pathways that differ between two tissues/conditions based on a list of differentially 
expressed genes, in an approach generally known as over-representation analysis 
(ORA) [72]. However, there are several limitations in this approach: a) the gene list 
is selected by some statistical measurements (e.g. fold change, t-test); sometimes, 
the power of these measurements is reduced by sample size; b) just significant 
differential genes are selected, which may lose some information of other relevant 
genes; c) each gene is treated equally and assumed to be independent; d) each 
pathway and GO term is assumed independent of other pathways and GO terms, 
which is not true; and, most importantly, e) a slight change in the threshold of the 
test statistic can lead to a total change in the ORA outcome, rendering its 
conclusions rather unstable.  
6.1.3 Direct-group Analysis 
In order to deal with the limitations of ORA, some investigators have tried to 
consider the distribution of the pathway genes in the entire list of genes, and assign 
some functional class scores (FCS) to different GO terms or pathways. For this type 
of methods, a gene-level statistic is computed first using molecular measurements 
 105 
 
from an experiment, such Pearson correlation, ANOVA [23], t-test [73] and Z-score 
[22]. The gene-level statistics for all genes in a pathway/GO term are aggregated 
into a single pathway/GO-level statistic, and compared with a null distribution 
obtained from random gene sets of the same size as the reference gene set (i.e. the 
pathway or genes belonging to the GO term) being studied. The pathway-level 
statistics used by current approaches include sum, mean, median of gene-level 
statistic [182], the Wilcoxon rank sum [74] and the Kolmogorov-Smirnov-like 
statistic in GSEA [21]. Although FCS-type methods are an improvement over ORA, 
they still have several limitations. First, similar to ORA, they also analyze each 
pathway/GO term independently. Second, when the pathway contains too many 
non-causal genes, the statistical score can be largely affected. These methods are 
more likely to identify pathways that contain a sufficiently large proportion of 
disease-related genes, but pathways that contain only a few phenotype-related 
genes may be missed [24].  
Further, some investigators attempted to incorporate some pathway topology 
information into the methods above. For example, Rahnenfuhrer et al. proposed 
ScorePAGE, which computes the similarity between each pair of genes in a 
pathway [183]. Then, the number of reactions needed to connect two genes in a 
given pathway is used to divide the pairwise similarities.  
6.1.4 Network-based Analysis 
In order to address the limitations that arise from direct-group analysis, network-
based methods identify a subset of genes that might be most relevant to a phenotype 
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for each pathway. They break up a pathway into smaller parts, called ‘sub-
networks’. Methods in this category include NEA [184], SNet [25] and PFSNet [24]. 
However, they still have some limitations. First, similar to other methods, they also 
consider each pathway independently. Second, for an experiment with very few 
samples, it is impossible to compute and estimate the P-value of the test statistic 
used by these methods. Third, these methods need a pathway database that has 
relevant large pathways; they do not work if some part of relevant pathway is 
missing or the relevant pathway is too small. 
6.1.5 Model-based Analysis 
Model-based methods are a category of gene-set-based methods that attempt to 
learn parameters for a dynamic model of any given pathway using one phenotype 
[24]. Different methods may use different models for pathways, such as linear 
models in SRI [75] and Petri nets in GGEA [26]. For this type of methods, a major 
drawback is that parameters are difficult to estimate when developing different 
models for pathways.  
6.2 Methods 
These existing methods share a number of limitations that make them unsuitable 
for the investigation of plant secondary metabolites. In such cases, we are typically 
comparing a mutant to the wild type. This extremely small sample size presents a 
severe challenge to all the methods mentioned above, even to the extent of 
rendering them inapplicable. Moreover, for plants without a reference genome, 
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their reference pathways are highly fragmented as there are many nodes in these 
pathways that we do not know what the corresponding genes/proteins are. This 
incompleteness directly affects the effectiveness of analysis methods that rely on 
pathway information. Lastly, almost all of the methods mentioned above consider 
each pathway independently. This does not seem reasonable in the context of 
metabolic pathways. In metabolic pathways, metabolites are produced and 
consumed. The amount of a metabolite that participates in two or more metabolic 
pathways has to be split among the two pathways [Figure 6.4]. Thus the activity 
(reflected as gene expression level) of the enzymes that process that metabolite 
should also be split among the two pathways. Analyzing gene expression in 
metabolic pathways without taking this into account potentially leads to more false 
positives and false negatives. 
We take the issues above into consideration, and propose here a “Weighted Pathway” 
approach for gene expression analysis of plant secondary metabolic pathways based 
on next-generation sequencing data. 
Figure 6.4 Model to deal with hub compound; Note: u,v,x,y denotes pathway; E,F,G,H denotes enzymes 
 
We assume that the abundance level of a compound is roughly correlated to the 
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gene-expression level of the enzymes catalyzing the production of that compound.  
After the gene-expression level of enzymes has been determined in one of the 
standard ways, the Weighted Pathway approach analyses metabolic pathways in 
three main steps. In the first step, the gene-expression level of each enzyme is 
adjusted taking into consideration the sharing of metabolites and enzymes across 
pathways. This produces the weighted pathways. In the second step, these weighted 
pathways are compared between the mutant and wild type and scored for 
significance. In the third step, which is an optional refinement, important sub-
networks in weighted pathways are identified. These steps are presented in 
subsections below, along with the preparatory steps of preparing the plant metabolic 
pathway database used here and determining the initial gene expression values of 
enzymes. 
6.2.1 Preparatory step 1: Database of plant metabolic pathway 
The expanding demand for the production of food, feed, medicine, and biofuel from 
plants has prompted the sequencing of plant genomes and transcriptomes. To date, 
genome and mRNA sequences are available for a large number of plant species, 
and many more are under way. However, only a few genome-wide metabolic 
network reconstructions exist for plants. These include, but are not limited to, 
Arabidopsis and poplar maps inferred from KEGG reference maps [185], 
Arabidopsis and rice reactions and pathways inferred from reactome human maps 
[186], and a number of databases inferred from MetaCyc [187], such as AraCyc for 
Arabidopsis [188], RiceCyc for rice 
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(http://pathway.gramene.org/gramene/ricecyc.shtml), MedicCyc for Medicago 
truncatula [189], LycoCyc for tomato 
(http://pathway.gramene.org/gramene/lycocyc.shtml) and ChlamyCyc for 
Chlamydomonas reinhardtii [190]. However, the lack of consistency in annotation 
standards and the lack of comparable quality in validation and curation hinder 
researchers seeking to meaningfully compare the metabolic networks of individual 
species housed in different metabolic databases.  
PlantCyc [191] is a comprehensive plant metabolic pathway database, which is 
created to collect metabolic networks from other databases related to plants. They 
have already unified the format and definition for each plant. Hence, we just need 
to extract all the pathways from different plants in PlantCyc [191] and remove 
redundancy between different plants. The resulting database is used as our 
reference metabolic pathway in downstream analysis, as discussed later. 
6.2.2 Preparatory step 2: Calculation of enzyme gene expression level 
We assume next-generation sequencing of the transcriptome of the mutant and wild 
type has been performed. Then, in our study here, after the de novo assembly of 
sequence reads into transcripts, RSEM (RNA-seq by Expectation-Maximization) is 
used to estimate the abundance of assembled transcripts [192]. Each transcript is 
then mapped to an enzyme in our pathway database by homology search. If multiple 
transcripts are mapped to the same enzyme, the sum of the transcripts’ abundance 
levels is used to represent the expression level of that enzyme. We call this value 
the “absolute expression level” of that enzyme. If we cannot find homologs in our 
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de novo assembled transcripts for some enzymes in a reference pathway, their 
absolute expression levels are set to zero.  
This preparatory step can be skipped or modified. For example, when gene 
expression values are directly supplied as input, we can simply use these gene 
expression values as the absolute expression levels of the enzymes.  
We acknowledge that the transcript abundance level and protein abundance level 
are not always tightly correlated. Nevertheless, many people have found that 
transcriptome analysis has similar results to proteome analysis [193]. Hence, the 
transcript abundance level is used as the absolute expression level of enzymes as 
described above. 
6.2.3 Main step 1: Relative gene expression level of enzyme 
In contrast to the absolute expression level of an enzyme, the “relative expression 
level” of an enzyme is defined later in this section with respect to a pathway, and is 
intended to reflect the amount of activity of the enzyme that contributes to that 
pathway.  For an enzyme that participates in multiple pathways, the sum of its 
relative expression levels with respect to these pathways is equal to its absolute 
expression level.  
In order to make the definition, let us first pay attention to hub compounds which 
link multiple pathways in the metabolic pathway database. Without loss of 
generality, let us consider the example in Figure 6.4. Let us assume that, over a 
fixed unit of time, the metabolite M is produced in pathways u and v (can be more 
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than 2), with amounts P(M,u) and P(M,v), and is consumed in pathways x and y 
(also can be more than 2), with amounts C(M,x) and C(M,y). Suppose the plant is 
in a steady state; i.e., the production and consumption of metabolites is in 
equilibrium. Thus: 
𝑃(𝑀, 𝑢) + 𝑃(𝑀, 𝑣) = 𝐶(𝑀, 𝑥) + 𝐶(𝑀, 𝑦) 
Rearranging the above equation, we get: 
                                       
𝐶(𝑀, 𝑥) =
𝑃(𝑀, 𝑢) + 𝑃(𝑀, 𝑣)
𝐶(𝑀, 𝑥) + 𝐶(𝑀, 𝑦)
× 𝐶(𝑀, 𝑥)                              𝑒𝑞𝑢𝑎𝑡𝑖𝑜𝑛 1 
                                        
𝑃(𝑀, 𝑢) =
𝐶(𝑀, 𝑥) + 𝐶(𝑀, 𝑦)
𝑃(𝑀, 𝑢) + 𝑃(𝑀, 𝑣)
× 𝑃(𝑀, 𝑢)                              𝑒𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2  
 
Since we do not have data from direct measurement of the abundance of metabolites, 
the value of P(M,_) and C(M,_) are unknown. However, using some initial 
estimates of the abundance of metabolites in the pathways, we could get better 
estimates. We proceed in stages (the outer loop, which estimates the relative 
expression level of enzymes in specific pathways) and in rounds (the inner loop, 
which estimates the production and consumption level of metabolites in specific 
pathways): 
𝐶(𝑀, 𝑥, 𝑖 + 1, ℎ) =
𝑃(𝑀, 𝑢, 𝑖, ℎ) + 𝑃(𝑀, 𝑣, 𝑖, ℎ)
𝐶(𝑀, 𝑥, 𝑖, ℎ) + 𝐶(𝑀, 𝑦, 𝑖, ℎ)
× 𝐶(𝑀, 𝑥, 𝑖, ℎ) 
                            
𝑃(𝑀, 𝑢, 𝑖 + 1, ℎ) =
𝐶(𝑀, 𝑥, 𝑖, ℎ) + 𝐶(𝑀, 𝑦, 𝑖, ℎ)
𝑃(𝑀, 𝑢, 𝑖, ℎ) + 𝑃(𝑀, 𝑣, 𝑖, ℎ)
× 𝑃(𝑀, 𝑢, 𝑖, ℎ) 
 
The index i is used to indicate the estimates of the production and consumption 
levels of metabolites in the pathways at round i. The index h is used to indicate the 
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estimates of the initial relative expression level of enzymes that produce or 
consume the metabolites in the pathways at stage h. 
At each stage h, if we iterate sufficiently long and these estimates converge, we 
obtain: 
                         
𝐶(𝑀, 𝑥, 𝑘 + 1, ℎ) = 𝐶(𝑀, 𝑥, 𝑘, ℎ) 
              
𝐶(𝑀, 𝑦, 𝑘 + 1, ℎ) = 𝐶(𝑀, 𝑦, 𝑘, ℎ) 
 
𝑃(𝑀, 𝑢, 𝑘 + 1, ℎ) = 𝑃(𝑀, 𝑢, 𝑘, ℎ) 
 
𝑃(𝑀, 𝑣, 𝑘 + 1, ℎ) = 𝑃(𝑀, 𝑣, 𝑘, ℎ) 
We denote the index value i at convergence in stage h by i’. Therefore: 
                            
𝐶(𝑀, 𝑥, 𝑖′, ℎ) =
𝑃(𝑀, 𝑢, 𝑖′, ℎ) + 𝑃(𝑀, 𝑣, 𝑖′, ℎ)
𝐶(𝑀, 𝑥, 𝑖′, ℎ) + 𝐶(𝑀, 𝑦, 𝑖′, ℎ)
× 𝐶(𝑀, 𝑥, 𝑖′, ℎ) 
 
𝑃(𝑀, 𝑢, 𝑖′, ℎ) =
𝐶(𝑀, 𝑥, 𝑖′, ℎ) + 𝐶(𝑀, 𝑦, 𝑖′, ℎ)
𝑃(𝑀, 𝑢, 𝑖′, ℎ) + 𝑃(𝑀, 𝑣, 𝑖′, ℎ)
× 𝑃(𝑀, 𝑢, 𝑖′, ℎ) 
Hence, we can obtain the production and consumption value of M in the pathways 
u, v, x and y based on the estimates of the relative expression level of enzymes in 
the pathways in stage h. We call this procedure “adjust pathway”, which tries to 
adjust the production/consumption level of metabolites in the pathways. 
Since we do not directly measure the abundance level of metabolites, we estimate 
these values based on the relative expression level of the corresponding enzymes, 
which produce and consume the metabolites. Thus, the initial values are: 
𝑃(𝑀, 𝑢, 0, ℎ) = 𝑅(𝐸, 𝑢, ℎ) 
𝑃(𝑀, 𝑣, 0, ℎ) = 𝑅(𝐹, 𝑣, ℎ) 
𝐶(𝑀, 𝑥, 0, ℎ) = 𝑅(𝐺, 𝑦, ℎ) 
𝐶(𝑀, 𝑦, 0, ℎ) = 𝑅(𝐻, 𝑦, ℎ) 
Here, R(_,_,h) denotes the stage-h estimates of the relative expression level of the 
corresponding enzymes in the specific pathways that produce or consume the 
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metabolite M. Hence E and F are the enzymes that produce M in pathways u and v 
respectively, and G and H are the enzymes that consume M in pathways x and y 
respectively. 
After convergence at round i’ in stage h, we can make the stage h+1 estimate of 
how much of the expression of an enzyme, for example E in Figure 6.4, that 
produces M contributes to a pathway x: 
𝑅(𝐸, 𝑥, ℎ + 1) = 𝐴(𝐸) ×
𝐶(𝑀, 𝑥, 𝑖′, ℎ)
𝐶(𝑀, 𝑥, 𝑖′, ℎ) + 𝐶(𝑀, 𝑦, 𝑖′, ℎ)
 
Here, A(E) is the absolute expression of an enzyme E that produces the metabolite 
M. Also, we initialize R(E,x,0)=A(E). This estimate of R(E,x,h+1) assumes, not 
unreasonably, that the production of the metabolite M by multiple enzymes are 
pooled before being consumed. The value R(E,x,h) is called the relative expression 
level of enzyme E in pathway x at stage h. We call this estimation procedure “split 
pathway”, which tries to split the absolute expression level of an enzyme into the 
pathways it is involved in.  
However, in the whole pathway database, there are some specific metabolites, 
which have no producer or no consumer. In order to deal with these metabolites at 
the boundary of a pathway, we first merge all the pathways into one big pathway. 
Then some artificial start enzymes and end enzymes are added into pathways for 
these boundary compounds. The absolute expression level for these artificial 
enzymes is set to the sum of the absolute expression level of all the enzymes which 
produce/consume the respective compounds.  
Each procedure---adjust pathway and split pathway---is run iteratively on hub 
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compounds and enzymes that produce or consume hub compounds. During 
iteration, if the percentage change at each and every enzyme between two 
successive rounds is small enough [<5%], the iteration process stops. Note that 
enzymes that produce or consume non-hub compounds are not touched by this 
iteration process; thus their relative expression levels are equal to their absolute 
expression levels. We use the term “weighted pathway” to refer to a pathway 
annotated with the relative expression level of enzymes with respect to this pathway. 
6.2.4 Main step 2: Identifying significant pathways 
The overall expression level O(P, S) of a given weighted pathway P, in a given 
sample S, can be defined based on the relative expression level of enzymes with 
respect to that pathway. A simple choice is to set O(P,S) as the median or mean of 
the relative expression level of enzymes in pathway P in sample S. In this study, the 
mean is used. 
There is no good applicable statistical method for determining which pathway P is 
significantly different in overall expression level between a mutant sample M and 
the wild-type sample W, due to this extremely small sample size of 2. A possible 
alternative is to consider the magnitude of the difference between the two overall 
expression levels, |O(P, M) – O(P, W)|. However, in this case, a small percentage 
difference between the two when O(P,M) is a high overall expression level can rank 
the pathway substantially higher than a large percentage difference when O(P,M) is 
a medium overall expression level. This is not reasonable. Another alternative is to 
consider the ratio between the two overall expression levels, O(P,M)/O(P,W).  
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However, in this case, a small magnitude difference between the two when O(P,M) 
is a low overall expression level can still result in a high ratio. This is also 
problematic. 
So we propose a practical compromise. We compute the overall expression level 
O(Pi, M) of each pathway Pi in the mutant sample M, and determine the mean M 
and standard deviation M of these overall expression levels. All pathways Pi with 
O(Pi,M) exceeding some threshold M (in this study, M = M, but other thresholds 
e.g., M = M + 2M can be used) are kept as candidates. Similarly, we also 
determine the mean W and standard deviation W of the overall expression level 
of pathways in the wild-type sample W, and all pathways Pi with O(Pi,W) 
exceeding some threshold W (in this study, W = W, but other thresholds e.g., W 
= W + 2W or even W = M can be used) are also kept as candidates. Note that M 
and W need not have the same value. For each candidate Pi, we compute its fold 
change between the two phenotypes as the greater of the two ratios 
O(Pi,W)/O(Pi,M) and O(Pi,M)/O(Pi,W). Note that if the absolute/relative 
expression levels are in log base 2, fold change should be computed as |O(Pi,W) – 
O(Pi,M)| or as 2
|O(Pi,W) – O(Pi,M)|, depending on whether one prefers to think in log 
units. Candidate pathways are then ranked based on this change value. That is, we 
consider only pathways that have high overall expression level in either the mutant 
or the wild type, and rank them based on fold change. 
6.2.5 Main step 3: Extracting sub-networks 
A further refinement for pinpointing a more specific part of a weighted pathway 
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that is likely to cause the difference between the two phenotypes is to generate and 
consider sub-networks of each weighted pathways. Given any enzyme E in a 
weighted pathway P, we generate the sub-network EP by taking E and all the 
enzymes and metabolites that are down-stream of E in P to be the sub-network, and 
letting the enzymes in EP inherit their relative expression levels (with respect to the 
sub-network) in the mutant and wild-type samples from P. We keep only those sub-
networks having at least three enzymes (some other threshold is possible, but we 
use this threshold because a larger threshold would disqualify at least half the 
pathways in the database) and whose overall expression levels in the mutant sample 
M exceed M or whose overall expression levels in the wild-type sample W exceed 
W. We call these the candidate sub-networks. 
A sub-network EP in P is said to be an “ancestor” of another sub-network EP’ in P 
if, and only if, EP is a subset of EP’. In this case, we also say EP’ is a “descendant” 
of EP. We consider a candidate sub-network EP in P to be interesting if, and only if, 
the ratio of its overall expression levels between the two phenotypes is greater than, 
or equal to, that of every one of its ancestors and descendants in P that is also a 
candidate sub-network. Such an interesting sub-network EP basically suggests that 
the enzyme E and its down-stream effects form the part in P that shows the biggest 
difference between the two phenotypes. Interesting sub-networks from all the 
pathways are ranked based on fold change. 
6.3 Results 
6.3.1 Plant metabolic pathway database 
After removing redundancy from different plant metabolisms in PlantCyc (June 
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2013,lastest version) [191], 879 pathways, 3,455 compounds and 3532 reactions 
are used for our final plant metabolism pathway database. These numbers are a little 
different from the statistics from PlantCyc. This may be because they include the 
latest pathways submitted by other people, which have not yet been included in 
latest backbone database. Compared to other plant metabolism pathway databases, 
this one is much more comprehensive not only in the number of pathways captured, 
but also in the number of reactions. It also contains many more pathways, compared 
to KEGG [185], which collects pathways from all organisms [Table 6.1].  
Table 6.1 Statistic information for different pathway database 
 Pathways Enzymes Reactions Compounds 
PlantCyc 1,050 188,798 5,332 4,410 
AraCyc 597 9,041 3,490 2,613 
BarleyCyc 465 7,572 2,901 2,135 
BrachypodiumCyc 473 8,802 2,915 2,128 
CassavaCyc 491 10,007 3,058 2,232 
ChineseCabbageCyc 499 10,976 3,104 2,270 
ChlamyCyc 349 3,330 2,263 1,514 
CornCyc 508 14,818 2,958 2,271 
GrapeCyc 479 7,572 3,015 2,229 
MossCyc 416 7,805 2,713 1,901 
OryzaCyc 482 15,677 3,000 2,226 
PapayaCyc 481 5,714 2,999 2,220 
PoplarCyc 505 20,822 3,124 2,295 
SelaginellaCyc 421 6,462 2,737 1,987 
SetariaCyc 477 10,214 2,942 2,145 
SorghumBicolorCyc 480 8,630 2,939 2,141 
SoyCyc 520 20,317 3,105 2,273 
SwitchgrassCyc 479 17,319 2,985 2,184 
KEGG 455 
[172 relate to 
metabolism] 
6,166 9,485 17,150 
 
However, from the length distribution, we can see that our pathways tend to be short 
ones. Nearly half of the pathways in our database have just 3 enzymes [Figure 6.5]. 
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For this type of pathways, network-based pathway analysis methods---which 
attempt to find enriched sub-networks in a longer pathway---are not suitable. 
Figure 6.5 Histogram of length of pathways in our database 
 
For the plants we are studying, there are no reference genomes and very little 
sequencing information in public databases. The most common method for enzyme 
annotation is still just by homology search. However, the effect of homology search 
depends on the completeness of the enzyme database.  The number of enzymes 
for non-model plants in the database is still limited, which makes it is a challenge 
to map de novo assembled transcripts for enzymes in the database. For the pathways 
in our database, many pathways still have some missing enzymes [Figure 6.6]. 
However, it does not mean that these missing enzymes are really missing in our 
assembled unigenes. It may be just because we cannot find them in our assembled 
results.  
Therefore, it raises some challenges in applying traditional pathway-based gene 
expression profile analysis methods to them. If one or two enzymes are missing in 
these pathways, most traditional methods become inapplicable to our dataset. This 
is because most of them use correlation between different enzymes in the same 
pathway to score this pathway. If one pathway is left with just one or two non-
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missing enzymes, these correlation scores are meaningless.  
Figure 6.6 Histogram for missing enzyme ratio in our pathway database 
 
6.3.2 Validity of weighted pathway approach 
In order to verify the correctness of weighted pathway approach, two public 
datasets from Arabidopsis thaliana are used: VTE2 mutant and SID2 mutant. 
6.3.2.1 VTE2 mutant 
The enzyme EC-1.13.11.27 catalyzes the production of homogentisate, which is the 
substrate for enzymes RXN-2761 (for plastoquinol-9 biosynthesis I), RXN-2541 
(for vitamin E biosynthesis), and EC-1.13.11.5 (for tyrosine degradation I); see 
Figure 6.7. Our first validation dataset is a public dataset (GSE53990) of the VTE2 
mutant, in which the enzyme RXN-2541 is mutant. According to the experiments 
of Michel et al. [194], the level for vitamin E (tocopherols) is greatly reduced in the 
VTE2 mutant, compared to the wild type. Also, the level for carotenoids 
(plastoquinol-9 biosynthesis I is precursor) is elevated.  
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Figure 6.7 Model for VTE2 mutant in Arabidopsis 
 
We apply Weighted Pathway to analyse this dataset. As a preparatory step, RMA 
(Robust Multiple-Array Average) [195] is applied to obtain the absolute expression 
level (log base 2) for each gene. Then the relative expression level for each gene is 
computed as described in the first step of Weighted Pathway. We can already see a 
clear difference in the relative expression levels of the enzyme EC-1.13.11.27 in 
the three pathways (vitamin E biosynthesis, tyrosine degradation I, plastoquinol-9 
biosynthesis I) between VTE2 and the wild type (WT), whereas there is no 
difference in the absolute expression levels of the enzyme EC-1.13.11.27 in VTE2 
and the wild type in these pathways; see Table 6.2.   
Table 6.2 Expression level for enzyme EC-1.13.11.27. WT and VTE2: denote expression level using absolute 
expression level; WT_weighted and VTE2_weighted: denote using our weighted pathway model 
       EC-1.13.11.27 WT VTE2 WT_weighted VTE2_weighted 
plastoquinol-9 biosynthesis I 7.588548 7.58976 7.315344 7.443480154 
vitamin E biosynthesis 7.588548 7.58976 4.166117 2.071157721 
tyrosine degradation I 7.588548 7.58976 3.931097 3.891596291 
We also computed the overall expression level of each pathway based on the mean 
of relative expression levels of enzymes in the pathway, as described in the second 
step of Weighted Pathway (W=4.97 for WT and M=4.93 for VTE2 mutant). We 
see that the vitamin E biosynthesis pathway has a 1.54-fold (= 0.619 in units of log 
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base 2) reduction in overall expression in VTE2 compared to the wild type [Table 
6.3]. Considering only candidate pathways having overall expression level greater 
than mean in either WT or VTE2 mutant, we find that rank of vitamin E 
biosynthesis pathway is 9 [Table 6.4]. If we exclude pathways whose size is smaller 
than 3, the rank for this pathway is slightly improved [Table 6.4]. In addition, we 
see that the plastoquinol-9 biosynthesis I pathway has a slight 1.04-fold (= 0.056 in 
units of log base 2) increase in overall expression in VTE2 compared to wild type 
[Table 6.3]. Similarly, also considering only candidate pathways having expression 
level greater than mean in either WT or VTE2 mutant, rank of plastoquinol-9 
biosynthesis pathway is 229 [Table 6.4]. 
Table 6.3 Mean value for different pathway WT and VTE2 denotes mean value using absolute expression 
level; WT_weighted and VTE2_weighted denotes the mean value using our weighted pathway model 





vitamin E biosynthesis 7.940 7.633 -0.307 6.257 5.637 -0.619 
tyrosine degradation I 6.059 5.993 -0.066 5.786 5.340 -0.406 
plastoquinol-9 
biosynthesis I 
9.008 9.020 0.012 7.457 7.513 0.056 
 
After applying the third step in Weighted Pathway, the rank does not show a big 
difference [Table 6.4]. This is because the pathways in the database are very small 
and, hence, not many significant sub-networks are identified. 
Table 6.4 Rank for different pathways based on relative expression level for VTE2 mutant. rank (all) denotes 
rank using all the pathways; rank (>mean) denotes rank using pathways having relative expression level 
more than the mean in the wild type or mutant; rank (mean & size>3) denotes rank using pathways having 
relative expression level more than mean in wild type or mutant and size should be more than 3; rank (sub-
network) denotes rank using sub-networks. 




vitamin E biosynthesis 11 9 7 10 
tyrosine degradation I 29 23 13 28 
plastoquinol-9 
biosynthesis  




In contrast, if we compute the overall expression level of a pathway as the mean of 
the absolute expression levels of enzymes in that pathway, we would see a 1.24-
fold (= 0.307 in units of log base 2) reduction in the overall expressional level of 
the vitamin E biosynthesis pathway and a 1.01-fold (= 0.012 in units of log base 2) 
increase in the overall expression level of the plastoquinol-9 pathway [Table 6.3]. 
Considering pathways having expression level greater than mean in either WT or 
VTE2 based on absolute expression level, we find that rank for vitamin E 
biosynthesis pathway is 30, and rank for plastoquinol-9 pathway is 328 [Table 6.5]. 
It is clear that Weighted Pathway has more clearly identified the experimental 
observations of Michel et al. [Figure 6.8] [194]. 
Table 6.5 Rank for different pathways based on absolute expression level for VTE2 mutant. rank (all) denotes 
rank using all the pathways; rank (>mean) denotes rank using pathways having relative expression level 
more than the mean in the wild type or mutant; rank (sub-network) denotes rank using sub-networks. 
 rank(all) rank(>mean) rank (sub-network) 
vitamin E biosynthesis 34 30 38 
tyrosine degradation I 330 250 321 
plastoquinol-9 biosynthesis  524 328 460 
 
Although there is no direct evidence showing the decrease of tyrosine degradation 
I pathway under VTE2 mutant, several groups have reported that there is a 
correlation between vitamin E biosynthesis and tyrosine aminotransferase (the first 
enzyme in the tyrosine degradation pathway) [196-198]. Hence, it is also consistent 




Figure 6.8 Vitamin E level for wild type and VTE2 mutant in Arabidopsis [194] 
 
6.3.2.2 SID2 mutant 
The enzyme EC-4.2.3.5 catalyzes the production of chorismate, which is the 
substrate for enzymes EC-5.4.4.2 (for salicylate biosynthesis I and 1,4-dihydroxy-
2-naphthoate biosynthesis II), EC-2.6.1.85 (for 4-aminobenzoate biosynthesis and 
tetrahydrofolate biosynthesis II), EC-4.1.3.27 (for tryptophan biosynthesis) and 
EC-5.4.99.5 (for phenylalanine biosynthesis II and tyrosine biosynthesis); see 
Figure 6.11. Our second validation dataset is a public dataset (GSE25489) of the 
SID2 mutant, in which the enzyme EC-5.4.4.2 (ICS/SID2) is mutant. In 
Arabidopsis thaliana, systemic acquired resistance against pathogens has been 
associated with the accumulation of salicylic acid (SA) [199]. Garcion et al. have 
demonstrated the function and localization of ICS involved in SA biosynthesis 
[Figure 6.9] [200]. Furthermore, reduction was also observed for phylloquinone 






Figure 6.9 Functional roles of ICS. phylloquinone (B) and SA accumulation following UV induction (C) [200] 
 
Figure 6.10 Accumulation of Camalexin in Leaves of Arabidopsis Col-0 Plants, NahG Plants (control), and 
sid (ICS) Mutant [199]. 
 
In addition, another group have demonstrated that camalexin (derived from 
tryptophan biosynthesis pathway) levels in SID2 mutant were higher compared to 
wild type plants [Figure 6.10] [199, 201]. Camalexin plays a role in resistance 
against pathogens, as does SA. Hence, they hypothesize that in Arabidopsis 
thaliana, there may be several independent ways leading to disease resistance. After 
checking the whole pathway database, we find that all of these three pathways share 
the same intermediate compound chorismate with several other pathways. In other 
words, after silencing of SID2/ICS (EC: 5.4.4.2), the whole flow is shifted between 
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these pathways [Figure 6.11].  
Figure 6.11 pathway model for ICS (SID2) mutant 
 
Similar to the VTE2 dataset, we also apply Weighted Pathway to analyze this 
dataset. Then, relative gene expression level for each enzyme is computed for each 
pathway as described in the first step of Weighted Pathway. We can also see a clear 
difference in the relative expression levels of the enzyme EC-4.2.3.5 in the three 
pathways (salicylate biosynthesis I, 1,4-dihydroxy-2-naphthoate biosynthesis II, 
tryptophan biosynthesis) between SID2 and the wild type (WT), whereas there is 
no difference in the absolute expression levels of the enzyme EC-4.2.3.5 in SID2 
and the wild type in these pathways; see Table 6.6. 
Table 6.6 Expression level for enzyme EC-4.2.3.5 in WT and ICS mutant. WT and Mutant denote the absolute 
expression level. WT_weighted and Mutant_weighted denote the relative expression level by our weighted 
pathway model. 
EC-4.2.3.5 WT Mutant WT_weighted Mutant_weighted 
salicylate biosynthesis I 11.60815 11.83651 8.384705672 5.367518991 
1,4-dihydroxy-2-
naphthoate biosynthesis II  
11.60815 11.83651 2.821442017 0.1265 
tetrahydrofolate 
biosynthesis II 
11.60815 11.83651 2.804929406 3.211543938 
4-aminobenzoate 
biosynthesis 
11.60815 11.83651 2.806005723 3.256979408 
tryptophan biosynthesis 11.60815 11.83651 10.54118343 11.13955004 
phenylalanine 
biosynthesis II 
11.60815 11.83651 8.986942389 9.268036134 
tyrosine biosynthesis II 11.60815 11.83651 9.237783499 9.496374756 
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We also compute the overall expression level of each pathway based on the mean 
relative expression levels of enzymes in the pathway, as described in the second 
step of Weighted Pathway (with a W=5.55 for WT and M=5.51 for SID2 mutant). 
We observe that the salicylate biosynthesis pathway has a 4.02-fold (= 2.007 in 
units of log base 2) reduction in overall expression in SID2 compared to wild type 
[Table 6.7]. We also see that the 1,4-dihydroxy-2-naphthoate biosynthesis II 
pathway has a 1.68-fold (= 0.75 in units of log base 2) decrease in overall 
expression in SID2 compared to wild type [Table 6.7]. Considering only candidate 
pathways having expression level greater than mean in either WT or SID2 mutant, 
the ranks of these two pathways are 1 and 9 respectively, the rank of the tryptophan 
biosynthesis pathway is 22 [Table 6.8]. After applying the third step in Weighted 
Pathway, the ranks are not changed much [Table 6.8]. Again, this is due to the small 
size of our pathways. 
Table 6.7 Mean value for different pathway. WT and ICS denotes mean value using absolute expression. 
WT_weighted and ICS_weighted denote mean value using relative expression. 
pathway level WT ICS FC WT_weighted ICS_weighted FC 
salicylate biosynthesis I 10.45 9.53 -0.926 9.37503 7.3673 -2.007 
1,4-dihydroxy-2-naphthoate 
biosynthesis II (plants) 
7.57 7.22 -0.349 5.75 5.003964 -0.75 
tetrahydrofolate 
biosynthesis II 
8.45 8.58 0.13 6.88 7.067 0.187 
4-aminobenzoate 
biosynthesis 
8.11 8.219 0.103 0.93 1.08566 0.15 
tryptophan biosynthesis 10.7 11.09 0.388 10.57 11.016 0.44 
phenylalanine biosynthesis 
II 
10.5 10.7 0.126 9.709 9.795 0.086 











Table 6.8 Rank for different pathways based on relative expression level for SID2 mutant. rank (all) denotes 
rank using all the pathways; rank (>mean) denotes rank using pathways having relative expression level 
more than mean in WT or mutant; rank (mean & size>3 
 rank 
(all) 




salicylate biosynthesis I 1 1 1 1 
1,4-dihydroxy-2-naphthoate 
biosynthesis 
9 9 5 9 
tetrahydrofolate biosynthesis II 113 100 46 129 
4-aminobenzoate biosynthesis 144 X X 161 
tryptophan biosynthesis 24 22 11 24 
phenylalanine biosynthesis II 242 196 103 258 
tyrosine biosynthesis II 214 176 90 231 
In contrast, if we compute the overall expression level of a pathway based on the 
mean of the absolute expression levels of enzymes in that pathway, we would see a 
1.9-fold (= 0.926 in units of log base 2) reduction in the overall expressional level 
of the salicylate biosynthesis pathway and a 1.27-fold (= 0.349 in units of log base 
2) decrease in the overall expression level of the 1,4-dihydroxy-2-naphthoate 
biosynthesis II pathway [Table 6.7]. Considering pathways having expression level 
greater than the mean in either WT or SID2 based on absolute expression level, we 
find that the rank for salicylate biosynthesis pathway is 2, and the rank for 1,4-
dihydroxy-2-naphthoate biosynthesis II is 50 [Table 6.9]. It is clear that Weighted 
Pathway is able to more clearly identify the experimental observations of Garcion 









Table 6.9 Rank for different pathways based on absolute expression level for SID2 mutant. rank (all) denotes 
rank using all the pathways; rank (>mean) denotes rank using pathways having relative expression level 
more than mean in WT or mutant; rank (sub-network) 
 rank(all) rank(>mean) rank(sub-
network) 
salicylate biosynthesis I 2 2 2 
1,4-dihydroxy-2-naphthoate 
biosynthesis  
56 50 37 
tetrahydrofolate biosynthesis II 110 96 125 
4-aminobenzoate biosynthesis 257 199 271 
tryptophan biosynthesis 41 38 34 
phenylalanine biosynthesis II 220 180 232 
tyrosine biosynthesis II 173 143 191 
In summary, by these two simple examples, we can say that Weighted Pathway 
approach gives more reasonable results than the method using absolute expression 
level. 
6.4 Conclusion 
In this chapter, a weighted pathway model has been proposed to investigate 
different secondary metabolites for different plants. Different from previous 
analysis, the main advantage for our model is that we not only focus on the known 
pathways/compounds, but also try to predict the new functions/pathways for 
studied plants. We do not consider each pathway to be independent. Instead, two 
ideas---hub enzymes and hub compounds---are introduced into our model. From 
the verification results, we find that our weighted pathway approach is much more 
reasonable than traditional pathway analysis methods, which use absolute 
expression level.  
We believe our weighted pathway approach will not only predict new 
functions/metabolites, but also provide more clues/ideas for future research about 
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secondary metabolites. We will demonstrate this, in the next chapter, by applying 

























APPLICATION ON SECONDARY METABOLISMS 
7.1 Background 
Plants produce enormous variety of specialized metabolites among which terpenes 
are the largest and most structurally varied class of natural products. Many of these 
terpenes are produced and stored in specialized secretory structures called glandular 
trichomes [Figure 7.1]. They are the main components of plant essential oils. These 
terpenes provide protection for plants against a variety of herbivores and pathogens 
[17, 168] and are also commercially quite valuable. But our knowledge about the 
development of secretory glandular trichomes and terpene production and its 
regulation is very limited, making it difficult to engineer these metabolic pathways.  
Aromatic essential oil produced by Mentha species is the source of the best-known 
monoterpenes, menthol and carvone, which form the principal components of mint 
oil. They are extensively used in flavour and fragrance industries, pharmaceuticals 
and cosmetic products [202]. 
From the trichome of peppermint variety ( Mentha piperita), 1,316 randomly-
selected cDNA clones, or expressed sequence tags (ESTs) were produced, which 
led to the identification of many genes, enzymes and substrates involved in the main 
essential oil biosynthetic pathway [203, 204]. Given the technical limitations at 
their time of study, an EST approach would possibly identify only cDNAs which 
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are abundant in trichome. A recent proteomic analysis of spearmint PGT identified 
1,666 proteins of which 57 were predicted to be involved in secondary metabolisms 
[205]. But generation of sufficient genomic information with deep coverage is 
required to gain insights into the regulatory mechanism of terpene metabolism and 
glandular trichome development. This will promote successful engineering for 
improved yields or to develop mint as a platform for production of novel / altered 
terpenes. Mint is a well-suited plant for this as it is able to produce and store large 
amount of oils within trichome instead of exuding it on to the leaf surface. Storage 
within the trichomes also reduces the loss of volatile oils by emission into the 
atmosphere. 
High-throughput RNA sequencing (RNA-Seq) has increasingly become the 
technology of choice to generate a comprehensive and quantitative profile of the 
gene expression pattern of a tissue. Here, we try to give a comparative analysis of 
RNA-seq transcriptome of different tissues of mint---namely trichome, leaf without 
trichome (leaf-trichome), and leaf. In addition, we are also interested in whether 
mint has the capacity to produce other secondary metabolites and whether it is 
possible to engineer other secondary metabolisms using mint as the platform. 
Hence, in this chapter, we use our weighted pathway approach developed in the last 








Figure 7.1 Trichomes on spearmint leaf. a:Non glandular hairy trichome, b:Peltate glandular trichome (PGT), 
c: Capitate glandular trichome 
 
7.2 Methods 




7.2.1 RNA sequencing 
For mint samples, RNA libraries for trichome tissues and other control tissues are 
prepared [Figure 7.2] and sequenced by Illumina following the manufacturer’s 
instructions. Around 100 million reads of 101bp clean reads are generated from leaf, 
root, trichome and leaf without trichome (leaf-trichome) tissues, respectively [Table 
7.1], achieving a higher coverage compared to previous EST databases [17].  
Table 7.1 Statistic for RNA seq results 
organism tissue avg read size  raw reads   pair end  
mint leaf 101 115,404,986 yes  
mint root 101 91,153,220 yes  
mint Leaf-trichome 101 136,558,099 yes  
mint trichome 101 115,191,961 yes  
As a first step, the quality for these sequencing reads is checked using the fastqc 
[http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc] tool box. If the raw reads 
have high quality [more than 70% bases having Quality score>=20, Figure 7.3], 
they are used in the next step. As these plants lack reference genome, only de novo 
assembly methods can be used. In the past several years, a lot of tools---such as 
SOAPdenovo [55], velvet [48], Oases [52] etc---have been developed for this 
purpose. Owing to the specific features for RNA assembly, such as alternative 
splicing, Trinity outperforms other methods, especially for RNA assembly [69]. 







Figure 7.3 Quality control for RNA seq result (box plot for each position in read)   x-axis: each base in read 
(bp)        y-axis: quality score for each base/position (20: base accuracy is 99%, 30: base accuracy is 
99.9%) 
 
7.2.2 Weighted pathway analysis 
As introduced in Chapter 6, after applying de novo assembly methods to assemble 
RNA-seq reads into transcripts, which represent different genes, transcriptome 
levels are mapped to enzymes as absolute expression levels. If we cannot find 
homologs in our de novo assembled transcripts for some enzymes, their absolute 
values are set to zero.  
Then, the relative expression levels for all enzymes producing/consuming hub 
compounds in the pathways are computed using our weighted pathway approach 
proposed in Chapter 6. Using the resulting relative expression levels of all enzymes 
in a pathway, the overall expression level of the pathway is computed. By 
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comparing overall expression level for each pathway between wild type and control, 
the enriched pathways are identified. We predict the potential new functions for our 
plants based on the enriched pathways.  
7.3 Results 
7.3.1 Results for RNA-seq 
In total, more than 40,000 unigenes [a unigene is a hypothetical gene represented 
by a cluster of similar transcripts that are thought to be isoforms in a de-novo 
transcriptome assembly] have been assembled for all species [Table 7.2]. This is 
more than the typical number of genes for most known organisms [2, 97]. Some 
genes may be partial ones; some of them may be non-coding genes, like lincRNAs. 
Table 7.2 Assembly results for the plant samples in our study 
Species # isoforms # unigenes total bases N50 GC percentage 
spearmint 87,480 40,587 101,396,693 1774 43.14% 
Functions of the unigenes are annotated based on sequence similarity to 
sequences in the public NR database [206]. At the same time, the protein 
sequence databases for Arabidopsis, Vitis and rice are also searched for homologs. 
For the mint dataset, among the 40,587 non-redundant unigenes, 27,025 (67%) 
have at least one hit in BLASTX search with E-value <= 1e-3. Functional 
classifications (GO term assignment) of all unigenes are done using Trinotate 
[69]. Then, the top 5000 up-regulated and down-regulated genes in trichome 
compared to leaf without trichome are selected for identifying enriched GO terms 





Figure 7.4 Enrichment GO items by hypergeometric test.  X-axis: log(1/p-value) a) Enrichment GO for 
trichome tissue of spearmint      b) enrichment GO for leaf tissue of spearmint 
 
From the top 20 enriched GO terms for trichome and leaf tissue [Figure 7.4], we 
see that the photosynthesis-related GO terms are only enriched in leaf tissue; 
while terpene synthase-related GO terms are only enriched in trichome tissue. 
This is consistent with the fact that terpene are only produced in trichome of mint 
[207]. However, it is still unknown why mint trichome does not have 
photosynthesis-related GO function, which is a major source of energy. 
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Figure 7.5 Heatmap for different tissue in spearmint and stevia samples 
 
In order to obtain the relative expression level for the assembled unigenes of each 
tissue, we first map reads onto them using bowtie [208]. RSEM [192] is then used 
for abundance estimation for the assembled transcripts to measure the expression 
level. From the heatmap shown in Figure 7.5, some specific patterns for trichome 
tissue in mint can be found. In other words, trichome tissue has some specific 
functions different from leaf and root. Among the specific patterns for trichome 
tissue, genes like P450, terpene biosynthesis, lipid transfer proteins (LTP) and 
interesting transcription factors like MYB, NAC are found, which may show good 
evidence for their potential function for the biosynthesis of specific secondary 
metabolites. An interesting finding is that we do not find any transcription factors 
(TFs) that matched major known trichome initiating TFs from Arabidopsis like 
TTG1, GL2,GL3 or Gl1 [209]. This may be the difference between glandular 
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trichome for mint and stevia and non-glandular trichome in Arabidopsis. In 
addition, one of the terpene synthase genes (TPS) in mint which showed a 
trichome-specific pattern [Figure 7.5] and has no homolog in the NR [206] 
database, has now been functionally characterized as sesquiterpene synthase in 
our lab [Figure 7.6].   
Figure 7.6 In vitro enzymatic assays of recombinant MsTPSs. GST-tagged MsTPS recombinant enzymes were 
purified by glutathione-based affinity chromatography and used for in vitro assays with GPP or FPP as 
substrate. The final products were analysed by GC-MS. 
 
7.3.2 Results for weighted pathway approach 
7.3.2.1 Enriched pathway for weighted pathway approach 
As mentioned in the method part, after computing the relative expression level for 
each enzyme in the pathway database, we also compare the overall expression level 
of pathways by different measurements, such as mean, median, sum and FCS 
methods. We summarized the top 20 enriched pathways by our weighted pathway 




Table 7.3 Top 20 enrichment pathway for trichome and other tissue in mint by our weighted pathway model    
Where each row denotes a pathway; column (leaf, root, leaf-trichome, trichome) denotes the overall 
expression level for a pathway by mean value of the enzyme in the pathway; FC denotes fold change 
between trichome and leaf-trichome using mean overall value; median and sum denotes overall expression 
level for trichome tissue by median value and sum value of the enzymes in the pathway; Pearson denotes 
the score for a pathway by the average Pearson correlation among one pathway; scorePAGE denote the 
score computed by scorePAGE method [183] 











(4R)-carvone biosynthesis 58.1 592 128.6 586
4 



















adenine and adenosine salvage 
VI 
713 463 410 164
8 
4 1648 1648 0 0 
geranylgeranyldiphosphate 
biosynthesis 
86.8 288 154.6 139
5 
9.0 1394.6 1394.6 0.00 0.000 





221 200.9 886 4.4 0.1 3545.3 -0.13 -
0.033 




63 33.6 851 25.4 851.9 851.9 0.00 0.000 
trans, trans-farnesyl diphosphate 
biosynthesis 
42.9 98 110.8 744 6.7 571.8 2232 0.78 0.789 
pinobanksin biosynthesis 23.0 107 97.7 683 7.0 25.0 3416 -0.59 -0.59 
casbene biosynthesis 1.4 32 3.2 582 183 582 582 0.00 0.000 




325 190.2 587 3.1 578 2935 0.94 0.674 
monoterpene biosynthesis 17.5 24 39.2 575 14 0.0 4607 0.99 0.124 
all-trans-farnesol biosynthesis 44.7 29 75.1 558 7 2.2 2232 0.78 0.780 
geranyl diphosphate 
biosynthesis 
114 50 68.4 554 8.1 553.7 553 0.00 0.000 
palmitate biosynthesis II 
(bacteria and plants) 
94.2 203 97.1 420 4.3 84.9 12186 0.65 0.398 
jasmonic acid biosynthesis 190 124 132.6 389 2.9 361.3 7395 0.52 0.329 
stearate biosynthesis II (bacteria 
and plants) 
98.3 207 113.3 381 3.4 132.2 1904 0.34 0.212 
pentose phosphate pathway 
(oxidative branch) 
92.6 66 43.1 306 7 97.4 1224 0.59 0.591 
flavonoid biosynthesis (in 
equisetum) 




7.3.2.2 Comparison between GC-MS result and weighted pathway approach result 
For our spearmint sample, by GC-MS analysis [Figure 7.7], it is clear that the major 




Figure 7.7 GC-MS result for spearmint sample 
 
At the same time, in addition to carvone, there are also slightly weaker peaks related 
to the sesquiterpene. From our weighted pathway approach [Table 7.3], we can see 
the most abundance pathway in trichome is also carvone biosynthesis. In addition, 
the sesquiterpene-related pathways, such as all-trans-farnesol biosynthesis and 
trans, trans-farnesyl diphosphate biosynthesis are also present in our results, which 
is consistent with GC-MS analysis. However, by our weighted pathway approach, 
we see that diterpene, such as casbene biosynthesis, is also enriched in trichome 
tissue, which is not found in the GC-MS analysis. This may be because that GC-
MS can only detect volatile metabolites. For non-volatile metabolites, like casbene, 
special gasification technique may be needed, if we use GC-MS technique. 
7.3.2.3 Comparison with other pathway analysis methods  
In section 6.2, we have mentioned that there are several limitations for traditional 
FCS methods and network-based methods. First, they do not consider dependence 
between each pathway. However, in our study, we use the relative expression level, 
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not absolute expression level. Second, we have shown that pathways in our 
database tend to be shorter and have missing enzymes [Figure 6.5 and 6.6]. Hence, 
for FCS-like methods, some statistical correlation score is not applicable for our 
dataset. For network-based methods, they are much more applicable for longer 
pathways. 
Therefore, we consider using mean, median, and sum value to compute overall 
expression level for pathways individually. For sum value, it always gives priority 
for longer pathways. This is because the longer a pathway is, the more enzymes are 
in the pathway. Mean value can be affected by some outliers, especially with only 
several highly expressed enzymes. Although median is less affected by outliers in 
large pathways, it does not take into account the precise value of each enzyme and 
it may not be robust for pathways that are very short. 
It is very difficult to compare the results to determine which method is better, 
because it is difficult to say the enriched pathway set from which method is more 
interesting to the investigator. Commonly, most people explore the meaning of their 
enriched pathways just by literature search.  
In our study, based on published results in mint, and in comparison with GC-MS 
results, transcriptome results, mean and median value for the overall expression 
level always produced relatively better result than sum value. When we go through 
the top enriched list [Table 7.3], the enriched pathways by mean and median are 
more reasonable for the plants we study.  
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7.3.2.4 Comparison between results based on absolute expression level and relative 
expression level 
We mentioned earlier that it is reasonable to use the relative expression level, not 
the absolute expression level, for every enzyme in the pathway database. In order 
to evaluate the merit of this method, we list the top 20 enriched pathways for mint 
using the absolute expression level for every enzyme in Table 7.4. By comparing 
this result with our top 20 enriched pathways based on relative expression level in 
Table 7.3, we see that the major different pathways are: methionine degradation I 
(to homocysteine) (rank drops from 5 based on absolute expression level to 37 
based on relative expression level), isoflavonoid biosynthesis I (rank drops from 13 
based on absolute expression level to 403 based on relative expression level). 
For methionine, the reason for not being in the top 20 pathways based on the relative 
expression level is because of the existence of hub compounds and hub enzymes. 
By the relative expression level, the overall expression level for this pathway is 
decreased in our results. This pathway is not related to known major secondary 
metabolisms for mint. Hence, it is much more biologically reasonable that this 
pathway is not enriched in our mint sample. 
For the isoflavonoid biosynthesis I pathway, it shares one hub enzyme with 
flavonoid biosynthesis. By relative expression level, flavonoid biosynthesis has 
higher relative expression level than isoflavonoid biosynthesis for this hub enzyme. 
Hence, flavonoid biosynthesis is in the top 20 list based on relative expression level, 
but not isoflavonoid biosynthesis. Phenylpropanoids are the main mediators of 
plant responses to abiotic and biotic stress and they are vital to plants resistance 
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towards pests [56], which is enriched in top 20 pathways for both results. 
Furthermore, phenylpropanoids serve as a rich source of metabolites for production 
of many other compounds like flavonoids, lignans and coumarins. Therefore, 
flavonoid biosynthesis, producing flavonoids, is much more reasonable than 
isoflavonoid biosynthesis, whose product is not related to known major secondary 
metabolites for mint. 
Table 7.4 Top 20 enriched pathway for mint by absolute expression level for each enzyme. Trichome denotes 
the overall expression level using the absolute value; our method denotes overall expression level for 
trichome tissue based on our solution, rank is the rank for each pathway in our solution; hub compound 











(4R)-carvone biosynthesis 5985.65 5864.77 1 1 1 
S-adenosyl-L-methionine biosynthesis 3545.07 3545.07 2 0 0 
geranyl diphosphate biosynthesis 1660.99 553.66 14 0 0 
adenine and adenosine salvage VI 1648.53 1648.5 4 0 1 
methionine degradation I (to 
homocysteine) 
1617.82 617.82 37 2 2 
menthol biosynthesis 1532.1 961.5 6 1 2 
methylerythritol phosphate pathway 1483.57 1687 3 1 0 
geranylgeranyldiphosphate biosynthesis 1396.59 1394.5 5 0 1 
2'-deoxymugineic acid phytosiderophore 
biosynthesis 
886.32 886.3 7 2 2 
pinobanksin biosynthesis 866.62 683.3 10 2 0 
pentose phosphate pathway (oxidative 
branch) 
844.04 306.4 19 0 1 
trans, trans-farnesyl diphosphate 
biosynthesis 
744.27 744.27 9 3 2 
isoflavonoid biosynthesis I 684.1 0.79 403 2 3 
fatty acid beta-oxidation II (peroxisome) 589.88 587.124 12 3 3 
casbene biosynthesis 582.01 582 11 0 0 
monoterpene biosynthesis 575.88 575.83 13 0 0 
free phenylpropanoid acid biosynthesis 567.92 851.885 8 1 2 
all-trans-farnesol biosynthesis 558.2 558.2 14 3 3 




7.3.2.5 Comparison between results based on transcriptome analysis and weighted 
pathway approach 
By transcriptome analysis, from the top differential expression gene list, we obtain 
some interesting candidates, which have potentially important functions related to 
secondary metabolisms. By our weighted pathway approach, we can predict some 
new functions for our plant samples. Here, we provide some simple explanation for 
our weighted pathway approach in sections below. 
 MEP pathway is more enriched than MVA in trichome 
After applying our weighted pathway model to our spearmint dataset, we find a lot 
of enriched pathways for trichome tissue, in addition to the known ones. From the 
result shown in Table 7.3, we can see that, not only carvone biosynthesis pathway, 
monoterpene, methylerythritol phosphate pathway, but also sesquiterpene (trans, 
trans-farnesyl diphosphate biosynthesis), diterpene (geranylgeranyldiphosphate 
biosynthesis), casbene biosynthesis are enriched in the trichome tissue for 
spearmint sample. Most of them are consistent with the metabolite results obtained 
from the GC-MS analysis. 
From the known biosynthesis pathways shown in Figure 6.1, all isoprenoid 
compounds are produced by two universal 5-carbon precursors; isopentenyl 
diphosphate (IPP) or dimethylallyl diphosphate (DMAPP). Through evolution, two 
non-related biosynthetic routes have been selected for the synthesis of these two 
basic building blocks which use different precursors, MEP and MVA.  
Based on our results, we conclude that the MEP pathway is the predominant route 
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for spearmint. In contrast, MVA pathway is not as highly enriched as the MEP 
pathway. In other words, the carbon source for terpene synthesis in spearmint 
mainly comes from CO2 and acetyl-CoA, which is consistent with our q-PCR 
verification [Figure 7.8].  
Figure 7.8 Q-PCR verification for several enrichment pathway predicted by our model 
 
 Energy production model 
Secretory trichomes are biosynthetically very active; hence, the energy requirement 
in these cells would presumably be more compared to other cell types. Like the 
result in section 7.3.1, trichome tissue does not express photosynthesis-related 
genes/enzymes. In addition, mint PGT trichome lacks chloroplasts. It is unknown 
where the energy for this specific trichome tissue comes from. 
Analysis of our transcriptome data shows that most of the primary energy-
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producing pathways are highly enriched in PGT, like glycolysis and TCA cycle. 
Also, Fatty acid beta-oxidation II (peroxisome) degrading fatty acids is also 
enriched in PGT. Fatty acid β oxidation pathway is a process by which fatty acids 
are broken down to produce acetyl–coenzyme A (CoA) and it can feed the TCA 
cycle. Acyl-CoA oxidases (ACX) (in peroxisomes) catalyzes the first step in fatty 
acid β-oxidation and 3-ketoacyl-CoA thiolase (KAT) catalyzes the key step in fatty 
acid beta-oxidation. Gene transcripts encoding of these enzymes have been verified 
by q-PCR and found to be enriched in PGT [Figure 7.8]. Hence, these results show 
that mint trichome can obtain the necessary energy by degrading fatty acid into the 
TCA cycle. That also explains the high enrichment of the lipid transfer protein in 
trichome tissue, which may have potential function in transferring lipids from leaf 
to trichome. 
Another evidence is that transcripts for several ABC transporters are enriched in 
trichome tissue, which may imply that trichome depends on the underlying leaf 
tissues for importing of carbon source. 
In summary, for the trichome tissue in spearmint, it may have two main energy 
sources: carbon source from leaf tissue and degradation of fatty acid to carbon in 
trichomes themselves. Further experiment is needed to verify which the main 
source is. 
 Trichome as plants chemical defense organs 
Most glandular trichomes produce, store and secrete large amounts of different 
classes of secondary metabolites. The main classes of secondary chemicals that 
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have been found to be produced in trichomes include terpenoids, phenylpropenes, 
methyl ketones acyl sugars and defensive proteins. All of these compounds play an 
important role in plant defense. Apart from having an enriched monoterpene 
biosynthetic pathway, our weighted pathway approach also shows the enrichment 
of a few other pathways (free phenylpropanoid acid biosynthesis and flavonoid 
biosynthesis), which are important for plant defense in spearmint PGT trichome 
[Table 7.3].  
Phenylpropanoids are the main mediators of plant responses to abiotic and biotic 
stress. They are key to plant resistance towards pests [210]. Furthermore, they serve 
as a rich source of metabolites for production of many other compounds like lignans 
and coumarins. In Table 7.3, the PGT trichome shows enrichment of free 
phenylpropanoid acid biosynthesis, and flavonoid biosynthesis pathways. The 
presence of a variety of small molecular weight phenylpropanoids---e.g., caffeic, 
rosmarinic and ferulic acids---has been detected in leaves of different mint 
germplasm. Spearmint and peppermint leaves are known to produce rosmarinic 
acid which is a potent antioxidant [211]. Further staining for phenylpropanoids and 
GC-MS experiments confirm most of their presence in PGT trichome [Figure 7.7].  
Additionally transcripts coding for proteinase inhibitors (PI) and polyphenols are 
also found to be more represented in PGTs; these are involved with defense 
response of plants against herbivores and pathogens. 
In summary, except the known monoterpene function for trichome of spearmint, it 




In this chapter, our proposed weighted pathway approach is applied to the spearmint 
RNA-seq dataset. Comparing results obtained from GC-MS, transcriptome analysis 
with our weighted pathway approach, we uncover and verify several new 
interesting functions for the trichome tissue, such as the energy production and 
defense function.  
We believe our weighted pathway approach will not only predict new 
functions/metabolites, but also provide more clues/ideas for future research about 



















Next-generation sequencing techniques have been successfully applied in the plant 
metabolism community [27].  Benefitting from whole-genome sequencing 
techniques, after the release of the Pisifera oil palm genome, a key shell gene was 
found to be related to oil palm fruit formation [114]. Using RNA-seq technique, 
gene expression for a lot of plants, which have no reference genome yet, can be 
studied enabling pathway manipulation by transgenic methods. This is because 
there is no pre-designed probe or reference genome requirement for RNA-seq, 
which is different from array-based methods. 
Although next-generation sequencing techniques are valuable in plant metabolism 
research, there are still several limitations, especially on lipid and secondary 
metabolisms. As the highest oil-yielding crop in the world, genome resources for 
oil palm are still very limited. It will be interesting to assemble genome sequence 
of other oil palm variants and related trees, using the released genome of Pisifera 
oil palm. For secondary metabolisms, using RNA-seq technique, most previous 
research just focus on gene level or known secondary metabolism pathways. It is 
important to predict new functions/metabolites for the studied plants.  
We have proposed a much more comprehensive reference-based genome assembly 
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pipeline, which is used to assemble the Dura oil palm genome. In this method, we 
have developed some solutions for mis-assembled scaffold and repeat scaffold 
identification. From the validation on a gold-standard dataset, it is clear that our 
pipeline outperforms DBG-based de novo assembly methods and other reference-
based assembly methods. 
We have generated whole-genome sequencing data for Dura oil palm and applied 
our reference-based genome assembly pipeline to construct a draft genome for it. 
This is the second sequenced genome for the oil palm community. Evaluation by 
three independent methods---EST coverage, genome completeness and linkage 
map---has demonstrated the accuracy and completeness of our draft Dura genome. 
We have generated RNA-seq data of 24 samples from different oil palm tissues 
[mesocarp, kernel, leaf, root, pollen, and flower] and developmental stages, which 
are helpful in the gene annotation of the draft Dura genome. Finally, around 30,000 
protein-coding genes have been identified in the draft Dura genome, which is 
similar in size to the genome of rice [118], date palm [119] and other plants [2]. At 
the same time, ncRNA annotation, including tRNA, rRNA, miRNA and long 
noncoding RNA, are also conducted for this draft genome. Around 200 miRNA 
families, half of them have been verified by small RNA sequencing results, and 
1,000 long noncoding RNA have been identified. In addition, by resequencing 12 
different oil palm strains from three different oil palm groups: Dura, Pisifera and 
Tenera, we have obtained around 12 million high-quality single-nucleotide 
polymorphisms (SNPs). Using these population SNP data, we have identified 
hundreds of gene lost and appearance of start/stop codons during evolution, and 
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thousands of genes have higher diversity sites between different oil palm groups. 
Some of these variants are associated with important biological features, whereas 
others have yet to be functionally characterized.  
We have constructed an online GBrowse-based database and blast tool, which are 
useful for visualizing and searching genome information for oil palm. Using the 
database, researchers can easily visualize location information for genes, 
noncoding RNAs and their structures. At the same time, detail information, such as 
sequence, expression levels in different tissues and copy number of small RNA 
reads, can be visualized clearly. Using the BLAST tool, investigators can easily 
find homologs in oil palm, which can facilitate their experimental design and verify 
their hypothesis or ideas. 
We have proposed a weighted pathway approach, which considers the dependency 
between different pathways. Finally, the relative expression level, not absolute 
expression level, is used to compare different pathways and samples. By validation 
on two different datasets, our approach is shown to be more reasonable.  
We have applied this weighted pathway approach to our spearmint RNA-seq dataset, 
and identified several new pathways/metabolites for spearmint. At the same time, 
results obtained from GC-MS and Q-PCR are consistent with our prediction. 
8.2 Future work 
We have proposed a much more comprehensive reference-based assembly pipeline, 
which can utilize the genome from closely related species and reduce the depth of 
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genome sequencing. We hope this method can help the assembly of individuals for 
other genetically-related species. It will be interesting to explore the genetic 
variation or disease variation between different individuals. 
We have constructed a draft Dura genome for oil palm. Next, it will be important 
to identify key genes/TFs related to oil yield or oil quality. In addition, it is known 
that after Dura was cross pollinated with Pisifera, there was a quantum leap in oil-
to-bunch from 16% (Dura) to 26% (Tenera). However, the mechanism is still 
unknown at the molecular level. Therefore, it is important to explore the 
mechanism/reason for this dramatically improvement in oil yield.  
Using the identified SNPs, it is possible to select important markers for oil palm 
breeding. During the past thirty years, modern breeding methods based on 
quantitative genetics theory have been extremely successful in improving oil 
productivity. Hence, we hope more important markers can be identified to guide 
future breeding of oil palm. 
For the weighted pathway approach, more plants can be used to test this approach. 
At the same time, it is important to perform more validation on different datasets. 
We hope our model can help to predict additional new functions and metabolites 
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